Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1050.Time spend outdoors in summer,50234,-0.00836870983604293,0.0296594063457002,-0.0665011462736153,0.0497637266015294,0.777823299906594
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1060.Time spent outdoors in winter,48092,-0.0987638682909717,0.0326686674583548,-0.162794456509347,-0.0347332800725964,0.00250453403871263
CD300E,CMRF35-like molecule 2,Physical activities,X1070.Time spent watching television (TV),51454,0.250585767568709,0.0304069600634776,0.190988125844293,0.310183409293126,1.80011385111139e-16
CD300E,CMRF35-like molecule 2,Physical activities,X1080.Time spent using computer,48181,-0.136376857818112,0.0289557332669558,-0.193130095021345,-0.0796236206148784,2.49665459036609e-06
CD300E,CMRF35-like molecule 2,Physical activities,X1090.Time spent driving,43932,-0.143138765678435,0.0333796911665374,-0.208562960364849,-0.0777145709920219,1.81273737492022e-05
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1160.Sleep duration,52255,0.0842763881029413,0.0261835430728698,0.0329566436801165,0.135596132525766,0.00128961199058067
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35647,0.00300228581077444,0.0183075113276643,-0.0328804363914476,0.0388850080129965,0.869742559780029
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35647,0.00578008742957482,0.0175501653754629,-0.0286182367063325,0.0401784115654821,0.741904408361973
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35647,0.00316550811515842,0.01914084373605,-0.0343505456074996,0.0406815618378164,0.868650265147654
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35647,0.0105316631447174,0.0192281650209651,-0.0271555402963743,0.048218866585809,0.583902670863194
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35647,0.0303313283386441,0.0192539387886041,-0.00740639168701993,0.0680690483643082,0.115229062509492
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35647,0.0510827077409687,0.0490523740527369,-0.0450599454023958,0.147225360884333,0.29773306684003
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35647,0.0894031363058471,0.0513072500816316,-0.0111590738541509,0.189965346465845,0.081467766847615
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35647,0.00521929888013455,0.0328621785176367,-0.0591905710144334,0.0696291687747025,0.873812599839694
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35647,0.0177194685858126,0.0238704837106312,-0.0290666794870247,0.0645056166586498,0.45792224341687
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35647,0.00639871388980227,0.0156945867218327,-0.0243626760849898,0.0371601038645943,0.683506017647873
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35647,0.012143869227845,0.0235026832154593,-0.0339213898744551,0.0582091283301451,0.605382328325485
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35647,-0.00744484151864338,0.0126754492037145,-0.0322887219579238,0.0173990389206371,0.556993643688662
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35647,-0.00476817490578757,0.0165737496110761,-0.0372527241434968,0.0277163743319217,0.773589917624048
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35647,0.0180358688621673,0.023657463198779,-0.0283327590074396,0.0644044967317742,0.445863826318752
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35647,-0.00417781131516769,0.0222396330028996,-0.047767492000851,0.0394118693705156,0.850996752626751
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35647,0.0822105707053293,0.0342711625125388,0.0150390921807533,0.149382049229905,0.0164759109619842
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35647,0.0645301691228621,0.0325783293828918,0.000676643532394092,0.12838369471333,0.0476594934710556
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35647,0.0134260975466375,0.0172887435849528,-0.0204598398798699,0.0473120349731449,0.43743489606029
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35647,0.0102057504080026,0.0162608115953332,-0.0216654403188504,0.0420769411348556,0.530269476893963
CD300E,CMRF35-like molecule 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35647,0.0095629790512032,0.0207289868930033,-0.0310658352590833,0.0501917933614897,0.644574800073795
CD300E,CMRF35-like molecule 2,Health and medical history,X120040.Fatigue severity over the past week,35651,0.147641203645232,0.0547958301348195,0.0402413765809855,0.255041030709478,0.00707005994959812
CD300E,CMRF35-like molecule 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,35649,0.130860388839244,0.054386238443269,0.0242633614904364,0.237457416188051,0.0161504435963464
CD300E,CMRF35-like molecule 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,35651,0.143984461468951,0.057666188086287,0.0309587328198288,0.257010190118074,0.0125545298903194
CD300E,CMRF35-like molecule 2,Health and medical history,X120098.Mobility problems today,35655,0.329730274156901,0.0598040762511166,0.212514284704712,0.446946263609089,3.65366201025223e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X120099.Self-care problems today,35655,0.11207954608706,0.0909563883478087,-0.0661949750746451,0.290354067248765,0.217906580123981
CD300E,CMRF35-like molecule 2,Health and medical history,X120100.Problems doing usual activities,35655,0.209425959242189,0.0581996037235734,0.0953547359439853,0.323497182540393,0.000322567622863819
CD300E,CMRF35-like molecule 2,Health and medical history,X120101.Pain or discomfort today,35655,0.0235860141473288,0.0542809584833754,-0.082804664480087,0.129976692774745,0.663927370691948
CD300E,CMRF35-like molecule 2,Health and medical history,X120102.Anxiety or depression today,35655,-0.0537060704885539,0.0691132891514442,-0.189168117225385,0.0817559762482767,0.437144168642866
CD300E,CMRF35-like molecule 2,Health and medical history,X120103.Scale to indicate how health is today,35633,-0.016177106339149,0.00553534936171173,-0.027026391088104,-0.00532782159019403,0.00348432171776176
CD300E,CMRF35-like molecule 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35630,0.0939519537512053,0.0704035833677073,-0.0440390696495011,0.231942977151912,0.182094845669978
CD300E,CMRF35-like molecule 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35620,-0.00816475868454207,0.0732490513598317,-0.151732899349812,0.135403381980728,0.911250525276299
CD300E,CMRF35-like molecule 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35636,-0.0562661599230868,0.054883969413216,-0.16383873997299,0.0513064201268166,0.30531494519261
CD300E,CMRF35-like molecule 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35635,0.131276199354146,0.0565267566355757,0.0204837563484179,0.242068642359874,0.0202438949351672
CD300E,CMRF35-like molecule 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35646,0.211293104885133,0.0802745605047257,0.0539549662958707,0.368631243474396,0.00850534227907089
CD300E,CMRF35-like molecule 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,35625,0.0311933117774672,0.0785041812898138,-0.122674883550568,0.185061507105502,0.691125621263308
CD300E,CMRF35-like molecule 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,35639,0.0430245472927231,0.0780707278654884,-0.109994079323634,0.19604317390908,0.581586261280182
CD300E,CMRF35-like molecule 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35638,0.126524242626055,0.107026529598874,-0.0832477553877376,0.336296240639848,0.237179328871612
CD300E,CMRF35-like molecule 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35618,0.197068420988374,0.159246578608493,-0.115054873084273,0.50919171506102,0.215944940957561
CD300E,CMRF35-like molecule 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33477,0.257950644386613,0.0760109289906981,0.108969223564845,0.406932065208382,0.000696070009300981
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,50447,0.16920446393192,0.0624723843009456,0.0467585907020667,0.291650337161774,0.00676487075253244
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48649,0.0397505701139201,0.039366459669624,-0.037407690838543,0.116908831066383,0.312624140029655
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1289.Cooked vegetable intake,51802,-0.152114539799546,0.0273914500289888,-0.205801781856364,-0.0984272977427276,2.83383499708949e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50990,-0.179668154120706,0.0284944113801763,-0.235517200425852,-0.123819107815561,2.9300123024031e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1309.Fresh fruit intake,51720,-0.145838336400669,0.0283845920228868,-0.201472136765527,-0.0902045360358111,2.80082859204711e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1319.Dried fruit intake,50519,-0.195705120018764,0.0285782390360152,-0.251718468529354,-0.139691771508174,7.69011661524824e-12
CD300E,CMRF35-like molecule 2,Health and medical history,X134.Number of self-reported cancers,52462,0.19971127507809,0.0426879103153283,0.116042970860046,0.283379579296133,2.90742610142948e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52463,0.331284220909151,0.0290029448722534,0.274438448959534,0.388129992858767,3.88711293957633e-30
CD300E,CMRF35-like molecule 2,Health and medical history,"X136.Number of operations, self-reported",52463,0.220632330211005,0.0276268562444311,0.16648369197192,0.27478096845009,1.45619134036039e-15
CD300E,CMRF35-like molecule 2,Health and medical history,X137.Number of treatments or medications taken,52463,0.353872594009097,0.0278253893564727,0.29933483087041,0.408410357147783,6.26595882701228e-37
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1438.Bread intake,51830,0.0194093933922439,0.00334143512802798,0.012860180541309,0.0259586062431787,6.38026405012699e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1458.Cereal intake,51486,0.0413173570740665,0.0270272964276586,-0.0116561439241444,0.0942908580722775,0.126346331745868
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1488.Tea intake,51751,0.0129112121717235,0.00324065761593034,0.00655952324450002,0.019262901098947,6.79395283821572e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1498.Coffee intake,50764,-0.235869403578595,0.0273285233331599,-0.289433309311589,-0.182305497845602,6.50237994762562e-18
CD300E,CMRF35-like molecule 2,Diet and food preferences,X1528.Water intake,50575,-0.0474459525511577,0.0271768475554126,-0.100712573759766,0.00582066865745109,0.0808561595596265
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1568.Average weekly red wine intake,45076,-0.324037903488913,0.0322313403665932,-0.387211330607435,-0.26086447637039,1.04384413776085e-23
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,45074,-0.196014336089648,0.033057826090227,-0.260807675226493,-0.131220996952803,3.10276636366491e-09
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,45120,0.0546746055603493,0.0367187198796984,-0.0172940854038595,0.126643296524558,0.13650407542592
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1598.Average weekly spirits intake,45057,0.023145154887756,0.0345071803358204,-0.0444889185704519,0.090779228345964,0.502399473396033
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1608.Average weekly fortified wine intake,45108,-0.0704570133781443,0.0524209488447421,-0.173202073113839,0.0322880463575501,0.178947450747581
CD300E,CMRF35-like molecule 2,Lifestyle factors,X1737.Childhood sunburn occasions,46094,-0.15390160373716,0.0332802695202101,-0.219130931996772,-0.0886722754775483,3.78449797340373e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X1807.Father's age at death,50326,-0.00768022301628578,0.00313469727530134,-0.0138242296758764,-0.00153621635669515,0.0142909570378036
CD300E,CMRF35-like molecule 2,Health and medical history,X1845.Mother's age,32620,-0.031646513164733,0.0145961581436373,-0.060254983126262,-0.00303804320320391,0.0302166647447841
CD300E,CMRF35-like molecule 2,Health and medical history,X1873.Number of full brothers,52036,0.00972433145851803,0.0258991890516647,-0.0410380790827448,0.0604867419997809,0.707315504123504
CD300E,CMRF35-like molecule 2,Health and medical history,X1883.Number of full sisters,52044,0.0239388366907233,0.0261885653179262,-0.027390751332412,0.0752684247138585,0.360676573634796
CD300E,CMRF35-like molecule 2,Physical measures,X20015.Sitting height,52292,-0.000758732226137826,0.00418221027960312,-0.00895586437415993,0.00743839992188428,0.856040332220683
CD300E,CMRF35-like molecule 2,Cognitive function,X20016.Fluid intelligence score,36788,-0.161257692427324,0.0426807574430271,-0.244911977015657,-0.0776034078389912,0.00015915715683825
CD300E,CMRF35-like molecule 2,Cognitive function,X20018.Prospective memory result,37148,0.130451713592728,0.0518060915798533,0.028911774096216,0.231991653089241,0.0118192340503756
CD300E,CMRF35-like molecule 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36661,0.0159342388548774,0.00568455281938886,0.00479251532887527,0.0270759623808796,0.00507481383353221
CD300E,CMRF35-like molecule 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36643,0.00556227899837503,0.0056995033654198,-0.00560874759784778,0.0167333055945978,0.329134090863035
CD300E,CMRF35-like molecule 2,Cognitive function,X20023.Mean time to correctly identify matches,52154,0.0194544303391973,0.00340775681389893,0.0127752269839554,0.0261336336944392,1.1513309883799e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,49000,0.00979426316486148,0.00705990994856204,-0.00404316033432012,0.0236316866640431,0.165363750103814
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48545,-0.0159702232910956,0.0150157523947431,-0.0454010979847921,0.0134606514026009,0.287539239538156
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48512,-0.0300193653955727,0.019907720671312,-0.0690384979113443,0.00899976712019883,0.131589874322026
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48520,0.00450262169240056,0.0192495544366655,-0.0332265050034639,0.042231748388265,0.815059004485617
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48542,-0.0186328759822179,0.0133171325621852,-0.0447344558041009,0.00746870383966501,0.161779310665236
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#2.Illnesses of father_Stroke,48721,0.00068547429138854,0.00887476141222942,-0.0167090580765811,0.0180800066593582,0.938434513372464
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48663,0.0119289046734342,0.0108258558703044,-0.00928977283236247,0.0331475821792308,0.270523023789744
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48563,-0.0264493997667331,0.0140246033699459,-0.0539376223718271,0.00103882283836084,0.0593195342580743
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48719,0.024277582453396,0.00957563009095944,0.00550934747511548,0.0430458174316765,0.0112412080385057
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48707,0.00691334699919944,0.00887892232953852,-0.0104893407666961,0.0243160347650949,0.436210348348375
CD300E,CMRF35-like molecule 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48586,-0.00572834085030292,0.0126491854991622,-0.0305207444286608,0.019064062728055,0.65065287402559
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50124,0.0202392500687361,0.00771196740317914,0.00512379395850503,0.0353547061789673,0.00868660375054158
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49958,-0.0263275670022142,0.010042375436398,-0.0460106228575543,-0.00664451114687412,0.00875697347536157
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49868,0.00265615551138389,0.0223093829600747,-0.0410702350903625,0.0463825461131302,0.905228964075936
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49894,-0.00901283352718176,0.0139847757402162,-0.0364229939780055,0.018397326923642,0.519274828701002
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,50052,0.00942906592129048,0.00846803025450947,-0.00716827337754807,0.026026405220129,0.265510927351514
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49915,0.0392761440136305,0.0161888848910441,0.00754592962718408,0.0710063584000769,0.0152697871697556
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49901,-0.0181315202711517,0.0137118086647543,-0.04500666525407,0.00874362471176669,0.186073272983489
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49904,-0.0182321937072229,0.0120296469758204,-0.0418103017798308,0.00534591436538496,0.129634511244142
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49952,0.0491714113941694,0.0135086000903761,0.0226945552170322,0.0756482675713066,0.000273291594376554
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50100,-0.00439525507565258,0.00752021756247023,-0.0191348814980942,0.0103443713467891,0.558918185081483
CD300E,CMRF35-like molecule 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49961,-0.0147341833844222,0.0114947572468569,-0.0372639075882617,0.00779554081941735,0.19992091121606
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46287,0.00961185074484339,0.00970364849936327,-0.00940730031390862,0.0286310018035954,0.321924331788306
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46108,0.0115504347580438,0.0337567044987052,-0.0546127060594184,0.0777135755755059,0.732229370350048
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46099,0.0122498340366436,0.0356752181923209,-0.0576735936203053,0.0821732616935925,0.731323671030103
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46131,-0.0250590908802499,0.0148223591292955,-0.0541109147736691,0.00399273301316931,0.0909263315365504
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46124,0.00199750065732791,0.0201273157242383,-0.0374520381621792,0.041447039476835,0.92094629379969
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46158,0.0123062194699782,0.0161877015783253,-0.0194216756235393,0.0440341145634958,0.447133473506658
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46122,0.0330475838991497,0.0180280036929155,-0.00228730333896464,0.068382471137264,0.0668015380927842
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46117,0.0174949468108987,0.0182539001582228,-0.0182826974992179,0.0532725911210154,0.337863496027904
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46137,-0.0252934592177582,0.0148615694731935,-0.0544221353852175,0.00383521694970104,0.0887854707247918
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46152,0.0187525687036167,0.0175529646976695,-0.0156512421038156,0.053156379511049,0.285381495092856
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46329,0.00276359958202812,0.00819356986770061,-0.0132957973586651,0.0188229965227213,0.735903311645529
CD300E,CMRF35-like molecule 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46220,0.0245586726309022,0.0112401121372785,0.00252805284183626,0.0465892924199682,0.0289087754312593
CD300E,CMRF35-like molecule 2,Mental health,X20127.Neuroticism score,47472,0.0726300468365587,0.0274016211355347,0.0189228694109106,0.126337224262207,0.00804241963465137
CD300E,CMRF35-like molecule 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36788,-0.0425309503849227,0.0432643680271723,-0.12732911171818,0.042267210948335,0.325615179219129
CD300E,CMRF35-like molecule 2,Lifestyle factors,X20161.Pack years of smoking,37083,0.0448410819648203,0.00559020203157538,0.0338842859829326,0.0557978779467081,1.19626477699002e-15
CD300E,CMRF35-like molecule 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,37083,0.0456316389655673,0.00577595204964781,0.0343107729482576,0.056952504982877,3.15865493115493e-15
CD300E,CMRF35-like molecule 2,Cognitive function,X20191.Fluid intelligence score,34371,-0.0250677571827293,0.054094085123504,-0.131092164024797,0.0809566496593385,0.643089810494828
CD300E,CMRF35-like molecule 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34372,-0.0221078272524547,0.0554611889846803,-0.130811757662428,0.0865961031575186,0.690191183983556
CD300E,CMRF35-like molecule 2,Cognitive function,X20240.Maximum digits remembered correctly,33719,-0.091531503897704,0.0592989614605329,-0.207757468360349,0.0246944605649405,0.122765016897922
CD300E,CMRF35-like molecule 2,Physical measures,X20255.Spirometry QC measure,46381,-0.0232680057416013,0.0352613115727408,-0.0923801764241733,0.0458441649409707,0.509343840555954
CD300E,CMRF35-like molecule 2,Eye measures,X20261.avMSE,34358,0.0111285008053387,0.006314116175728,-0.00124716689908816,0.0235041685097656,0.0780474525171706
CD300E,CMRF35-like molecule 2,Eye measures,X20262.Myopia diagnosis,34358,-0.0674294775361335,0.0689972175009949,-0.202664023838084,0.0678050687658165,0.328477222821496
CD300E,CMRF35-like molecule 2,NMR metabolomics,X20280.Glucose-lactate,42644,-0.00537816193980657,0.00426158462340834,-0.0137308678016869,0.00297454392207378,0.206967111240492
CD300E,CMRF35-like molecule 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,42671,-0.0145577561300005,0.00436743850171966,-0.023117935593371,-0.00599757666662996,0.000860695902126237
CD300E,CMRF35-like molecule 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36459,-0.0813497671789635,0.0265953838794277,-0.133476719582642,-0.0292228147752852,0.0022304021458573
CD300E,CMRF35-like molecule 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36459,-0.0514907319770039,0.049994122614172,-0.149479212300781,0.0464977483467733,0.303074474581089
CD300E,CMRF35-like molecule 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36459,-0.126101688701567,0.0834417965100106,-0.289647609861188,0.0374442324580535,0.130767425166269
CD300E,CMRF35-like molecule 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36459,-0.0847030366881489,0.0244353541129646,-0.132596330749559,-0.0368097426267384,0.000530503535131006
CD300E,CMRF35-like molecule 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36459,-0.122713895965063,0.0507153254572713,-0.222115933861315,-0.0233118580688111,0.015559368758977
CD300E,CMRF35-like molecule 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36462,-0.107506892844081,0.0641268221352176,-0.233195464229107,0.0181816785409459,0.0936885664926597
CD300E,CMRF35-like molecule 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36462,-0.0458046761779705,0.0395151253057991,-0.123254321777337,0.0316449694213958,0.246425717801299
CD300E,CMRF35-like molecule 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36462,-0.0238620211009328,0.0477224167790407,-0.117397957987853,0.0696739157859869,0.617078224095021
CD300E,CMRF35-like molecule 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36462,0.030397351284067,0.0739434760624704,-0.114531861798375,0.175326564366509,0.681019379317944
CD300E,CMRF35-like molecule 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36462,-0.0389428725436842,0.0874551162761044,-0.210354900444849,0.13246915535748,0.656123589103685
CD300E,CMRF35-like molecule 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36462,-0.0291676852874415,0.0522285711943459,-0.131535684828359,0.0732003142534764,0.576545980215299
CD300E,CMRF35-like molecule 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36462,-0.0653212283484908,0.090485297942114,-0.242672412315034,0.112029955618053,0.470379920633627
CD300E,CMRF35-like molecule 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36462,-0.0578216658456429,0.0620018671532797,-0.179345325466071,0.0637019937747853,0.351068136937088
CD300E,CMRF35-like molecule 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36461,-0.150570131257437,0.084652348306261,-0.316488733937708,0.0153484714228349,0.075332692422384
CD300E,CMRF35-like molecule 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36461,-0.0716024710913374,0.0332024155964295,-0.136679205660339,-0.00652573652233558,0.0310739102911599
CD300E,CMRF35-like molecule 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36461,-0.0563349952550922,0.0610120499051237,-0.175918613069135,0.0632486225589502,0.355859602480258
CD300E,CMRF35-like molecule 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36463,-0.162979445828925,0.104547158640622,-0.367891876764545,0.0419329851066947,0.119061590948155
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20600.Liking for adding salt to foods,36299,-0.0667629235542296,0.0481932413414897,-0.161221676583549,0.0276958294750902,0.165999056523019
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20601.Liking for aniseed,36299,0.0073020443049504,0.0477778146526488,-0.0863424724142413,0.100946561024142,0.878534028810513
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20602.Liking for apple juice,36299,0.12623083980811,0.0482718252315722,0.0316180623542289,0.220843617261992,0.00894160972104444
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20603.Liking for apples,36299,-0.0496938587270935,0.0491865310640361,-0.146099459612604,0.0467117421584171,0.312379150910057
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20604.Liking for asparagus,36299,-0.208279078400501,0.0491757392545404,-0.304663527339401,-0.111894629461602,2.31024769867783e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20605.Liking for aubergine,36299,-0.226469564288498,0.0479192490672158,-0.320391292460241,-0.132547836116755,2.33321266628788e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20606.Liking for avocados,36299,-0.27875810698874,0.0485623183899918,-0.373940251033124,-0.183575962944356,9.84572580121288e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20607.Liking for bacon,36299,-0.0371147510474667,0.0484421064618635,-0.132061279712719,0.0578317776177858,0.443602332255361
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20608.Liking for baked or steamed fish,36299,-0.144544488496302,0.0489170873518951,-0.240421979706016,-0.0486669972865873,0.00313811038475766
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20609.Liking for bananas,36299,0.159914481058631,0.0505211398716517,0.0608930469101937,0.258935915207069,0.00155579132291651
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36299,-0.157256735107498,0.048020409720149,-0.25137673815899,-0.0631367320560061,0.00106247724639274
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20611.Liking for beef steak,36299,-0.0544956853008099,0.0480379391563925,-0.148650046047339,0.0396586754457194,0.256652488925536
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20612.Liking for beetroot,36299,-0.00401351431436815,0.0484612316897785,-0.0989975284263339,0.0909704997975976,0.933997738659754
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20613.Liking for bell pepper,36299,-0.127627958919514,0.0479511453409238,-0.221612203787724,-0.0336437140513029,0.00779397039191438
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20614.Liking for bicycling,36299,-0.183476136155538,0.0481608729140786,-0.277871447067132,-0.0890808252439441,0.000140338201438394
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20615.Liking for biscuits,36299,0.144848529250973,0.0481259156615241,0.050521734554386,0.239175323947561,0.00262353889129163
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20616.Liking for bitter foods,36299,-0.249897635757349,0.0482724289699957,-0.344511596538541,-0.155283674976157,2.31900344107244e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20617.Liking for bitter or ale,36299,-0.222634924053868,0.0491033697966806,-0.318877528855362,-0.126392319252374,5.88256528836288e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20618.Liking for black olives,36299,-0.282957325929292,0.0483305307064737,-0.37768516611398,-0.188229485744603,4.99401617159377e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20619.Liking for black pepper,36299,-0.201304765231852,0.0482969902329924,-0.295966866088517,-0.106642664375187,3.10853736406251e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20620.Liking for blue cheese,36299,-0.211202828314821,0.0481381658407294,-0.305553633362651,-0.116852023266992,1.1635700014108e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20621.Liking for bolognese sauce,36299,-0.16150535696633,0.0486890886480148,-0.256935970716439,-0.0660747432162209,0.000914226091976069
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20622.Liking for broad beans,36299,-0.151377392468265,0.0484662693710862,-0.246371280435593,-0.0563835045009357,0.0017952146666899
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20623.Liking for broccoli,36299,-0.177821241519908,0.0496925107647173,-0.275218562618754,-0.080423920421062,0.000347968936307386
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20624.Liking for brown rice,36299,-0.140792384214561,0.0480163083108002,-0.23490434850373,-0.0466804199253929,0.00337668805799316
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20625.Liking for brussel sprouts,36299,-0.0489181269608641,0.0486014394585306,-0.144176948299584,0.0463406943778559,0.314201733634858
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20626.Liking for burgers (meat),36299,-0.0186334012214617,0.0479777055234155,-0.112669704047356,0.0754029016044326,0.697749270557624
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20627.Liking for burn of spicy foods,36299,-0.186688132556995,0.0480311350353196,-0.280829157226222,-0.0925471078877688,0.000102493554808905
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20628.Liking for butter on bread,36299,0.0376408517304299,0.0484890024985325,-0.0573975931666939,0.132679296627554,0.437611878921917
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20629.Liking for butternut squash,36299,-0.135371931030028,0.0479960077690342,-0.229444106257335,-0.0412997558027211,0.00480844743255225
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20630.Liking for cabbage,36299,-0.0172274558942891,0.0487244761517036,-0.112727429151628,0.0782725173630499,0.723672543092274
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20631.Liking for cake,36299,0.14559548563013,0.0479292393248705,0.0516541765533837,0.239536794706876,0.00239244017434588
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20632.Liking for cake icing,36299,0.160200702852702,0.0479986290892125,0.0661233898378455,0.254278015867558,0.000849370282799729
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20633.Liking for capers,36299,-0.333260731428846,0.0476790427678736,-0.426711655253878,-0.239809807603813,3.00613087099178e-12
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20634.Liking for cauliflower,36299,-0.0272968530755415,0.0491654584045655,-0.12366115154849,0.0690674453974068,0.578772719055589
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20635.Liking for cereal or granola bar,36299,0.134628262328295,0.0475725051879132,0.0413861521599847,0.227870372496604,0.00466846794426445
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20636.Liking for cheesecake,36299,-0.0113591912906071,0.0480068843787005,-0.10545268467286,0.0827343020916458,0.812961627700934
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20637.Liking for cherries,36299,-0.105723168411248,0.0514631250219991,-0.206590893454367,-0.00485544336813019,0.0399785673321612
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20638.Liking for chicken,36299,0.00132629881645389,0.0505971572118458,-0.0978441293187639,0.100496726951672,0.979088254434456
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20639.Liking for chilli pepper,36299,-0.267982503898154,0.0481000115843403,-0.362258526603461,-0.173706481192847,2.6202288687675e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20640.Liking for chips or french fries,36299,-0.0300695215049793,0.0482817805252922,-0.124701811334552,0.0645627683245935,0.533441027513414
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20641.Liking for cigarette smoking,36299,0.038404668976449,0.0818421051468816,-0.122005857111439,0.198815195064337,0.638903086685021
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20642.Liking for cod,36299,-0.123529331573421,0.0500254798528512,-0.221579272085009,-0.0254793910618325,0.0135600655083257
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20643.Liking for coffee with sugar,36299,0.188376126978244,0.0522321245162379,0.0860011629264174,0.29075109103007,0.00031246493649499
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20644.Liking for coffee without sugar,36299,-0.246130230042719,0.0490158808181402,-0.342201356446274,-0.150059103639164,5.2536595340581e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20645.Liking for coriander,36299,-0.198637955770754,0.0477679746655227,-0.292263186115179,-0.10501272542633,3.242712803418e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20646.Liking for corn flakes,36299,0.173782909383048,0.0481576338464645,0.079393947043977,0.268171871722118,0.000309942186144237
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20647.Liking for cream,36299,-0.0448936277689074,0.0480617495691394,-0.13909465692442,0.0493074013866058,0.350293244109842
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20648.Liking for croissant,36299,-0.0165032610627877,0.0482622659461221,-0.111097302317187,0.0780907801916116,0.732398971015237
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20649.Liking for cucumber,36299,-0.0740117783716633,0.0485933445353366,-0.169254733660923,0.0212311769175964,0.127782083293864
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20650.Liking for curry,36299,-0.173778082897207,0.0482456371993816,-0.268339531807995,-0.0792166339864188,0.000318006275325902
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20651.Liking for dairy products,36299,0.0751171944227391,0.0490181492901958,-0.0209583781860446,0.171192767031523,0.125459368914345
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20652.Liking for dark chocolate,36299,-0.18335680678587,0.0491860726851846,-0.279761509248832,-0.0869521043229081,0.000194646420831817
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36299,0.107968358306598,0.0502430001512498,0.00949207801014824,0.206444638603048,0.0316741984697427
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20654.Liking for dried fruit,36299,-0.0416061660460899,0.0485723223188171,-0.136807917790971,0.0535955856987915,0.39170498685515
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20655.Liking for eggs,36299,-0.0602720087348475,0.0500428120454557,-0.158355920343941,0.0378119028742456,0.228471739799724
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20656.Liking for exercising alone,36299,-0.219113859663727,0.0477670321106875,-0.312737242600675,-0.12549047672678,4.57083714203383e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20657.Liking for exercising with others,36299,-0.154380292205329,0.0478361703133013,-0.2481391860194,-0.0606213983912588,0.00125544663305361
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36299,-0.205100770594038,0.0483054705260678,-0.299779492825131,-0.110422048362945,2.20483241386064e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20659.Liking for fatty foods,36299,-0.118600625145871,0.0476207727768252,-0.211937339788448,-0.0252639105032936,0.0127782208701622
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20660.Liking for fresh tomatoes,36299,-0.106707448905796,0.0519921465142015,-0.208612056073631,-0.00480284173796064,0.0401697089324306
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20661.Liking for fried chicken,36299,0.000389873665871103,0.0477775593951968,-0.0932541427487146,0.0940338900804568,0.993489416984884
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20662.Liking for fried or battered fish,36299,-0.0198463340887826,0.048158118273315,-0.11423624590448,0.0745435777269148,0.68027289196504
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20663.Liking for fruit,36299,-0.0387031932396266,0.0547657053080905,-0.146043975643484,0.0686375891642307,0.47977307747749
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20664.Liking for garlic,36299,-0.240911365265014,0.0485118214400895,-0.33599453528759,-0.145828195242439,6.99318475002526e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20665.Liking for gherkins,36299,-0.268400720727126,0.0477475098932526,-0.361985840117901,-0.174815601336351,1.96778238657913e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20666.Liking for globe artichoke,36299,-0.253803148439993,0.0482102409732162,-0.348295220747497,-0.159311076132489,1.44689652470376e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20667.Liking for goat's cheese,36299,-0.206506448539395,0.047772202841341,-0.300139966108423,-0.112872930970366,1.56214197869713e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20668.Liking for going to a cafe,36299,-0.0127849420714309,0.0479847871562592,-0.106835124897699,0.0812652407548372,0.789910104001824
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20669.Liking for going to the gym,36299,-0.203660106673857,0.0480169017882235,-0.297773234178775,-0.109546979168939,2.24926429931076e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20670.Liking for going to the pub,36299,-0.195363726438973,0.0481846683065919,-0.289805676319894,-0.100921776558053,5.07836095839543e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20671.Liking for grapefruit,36299,-0.0630578803791714,0.0481869250904915,-0.157504253556535,0.0313884927981919,0.190708954534809
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20672.Liking for green olives,36299,-0.316541377104475,0.0483665167982724,-0.411339750029089,-0.221743004179861,6.37948178951248e-11
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20673.Liking for haddock,36299,-0.185507493685434,0.0500317862483231,-0.283569794732147,-0.0874451926387207,0.000210667823954917
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20674.Liking for ham,36299,-0.0260920473885223,0.0484565953437415,-0.121066974262256,0.0688828794852111,0.59027484944381
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20675.Liking for hard cheese,36299,-0.12106294719385,0.049187694250812,-0.217470827925442,-0.0246550664622587,0.0138692201061294
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20676.Liking for herring,36299,-0.224611514643587,0.0478944310930481,-0.318484599585961,-0.130738429701213,2.78694114661324e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20677.Liking for honey,36299,0.0297811836916563,0.0484018643381494,-0.0650864704111165,0.124648837794429,0.538382943965494
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36299,-0.222154070344453,0.0475000454708307,-0.315254159467281,-0.129053981221625,2.965997462427e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20679.Liking for ice cream,36299,-0.0108396073396725,0.0485181679093183,-0.105935216441936,0.0842560017625912,0.823220231542216
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20680.Liking for jam,36299,0.111718125402784,0.0481159670076451,0.0174108300677996,0.206025420737768,0.0202691043648381
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20681.Liking for kiwi fruit,36299,-0.0598275505068551,0.0484341895871402,-0.15475856209765,0.0351034610839396,0.2167843798825
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20682.Liking for lager,36299,-0.155235248659589,0.0484191328479711,-0.250136749041613,-0.0603337482775659,0.00135156621679058
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20683.Liking for lamb,36299,-0.139076465976314,0.0485441862397503,-0.234223071006224,-0.043929860946403,0.00418305523663195
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20684.Liking for lemons,36299,-0.182541135871612,0.0484148388232184,-0.27743421996512,-0.0876480517781037,0.000164339319377193
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20685.Liking for lentils or beans,36299,-0.0890647176798227,0.0487226525529071,-0.184561116683521,0.00643168132387531,0.067592413332314
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20686.Liking for liver,36299,-0.228583274172631,0.0477754247595941,-0.322223106701436,-0.134943441643827,1.74845559665075e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20687.Liking for mackerel,36299,-0.217842190053209,0.048323648633342,-0.312556541374559,-0.123127838731859,6.64974991110768e-06
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20688.Liking for marzipan,36299,0.0125944375513475,0.0479173689405626,-0.0813236055721551,0.10651248067485,0.792684167409029
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20689.Liking for mayonnaise,36299,-0.0545046496006494,0.0479276606230436,-0.148442864421815,0.0394335652205161,0.255481628339424
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20690.Liking for melon,36299,0.0280205922893415,0.0504968736442756,-0.0709532800534387,0.126994464632122,0.578982216481236
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20691.Liking for milk chocolate,36299,0.169689748081385,0.047627321921108,0.0763401971160128,0.263039299046756,0.000369236421479158
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20692.Liking for mushrooms,36299,-0.10310678614795,0.0493691288431192,-0.199870278680463,-0.00634329361543601,0.0367894776916437
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20694.Liking for orange juice,36299,0.131706597028771,0.0483224554494151,0.036994584347918,0.226418609709625,0.00643465752383613
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20695.Liking for oranges,36299,-0.101868115674637,0.0493907303615173,-0.198673947183211,-0.00506228416606301,0.0391969819601965
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20696.Liking for pasta,36299,-0.0845649436610851,0.0488300142997736,-0.180271771688641,0.011141884366471,0.083348533553237
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20697.Liking for pears,36299,0.0731699339692773,0.0497740617286666,-0.0243872270189092,0.170727094957464,0.141594863049427
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20698.Liking for pizza,36299,-0.0835565322050677,0.0482243900613825,-0.178076336725377,0.010963272315242,0.0831993427566835
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20699.Liking for plain yogurt,36299,-0.153850102232257,0.0484883597694641,-0.248887287380406,-0.058812917084107,0.00151553488662361
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20700.Liking for plums,36299,0.0232868759151391,0.049702676995399,-0.0741303709958429,0.120704122826121,0.639424607607984
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20701.Liking for pollock,36299,-0.197291147563927,0.0475137036421657,-0.290418006702572,-0.104164288425283,3.33006160347169e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20702.Liking for pork chop,36299,-0.123576168970932,0.0479778508872861,-0.217612756710013,-0.0295395812318515,0.0100240196485502
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20703.Liking for porridge,36299,0.0125234458330604,0.0489808010495238,-0.0834789242240063,0.108525815890127,0.798204804583664
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20704.Liking for potato crisps,36299,0.0358073846213745,0.0479003146733947,-0.0580772321384791,0.129692001381228,0.454762646945069
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20705.Liking for potatoes,36299,0.110066378087592,0.0487592522547201,0.0144982436683407,0.205634512506843,0.0240168923990643
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20706.Liking for prawns,36299,-0.272071779103176,0.0492062574387396,-0.368516043683105,-0.175627514523246,3.33117724890058e-08
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20707.Liking for raw carrots,36299,-0.0605126930995834,0.04832783091307,-0.155235241689201,0.0342098554900339,0.210564020908351
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20708.Liking for red meat,36299,-0.0945058715657983,0.0483968879809671,-0.189363772008494,0.000352028876897115,0.0508913060470148
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20709.Liking for red wine,36299,-0.286721302071311,0.0482507835111856,-0.381292837753235,-0.192149766389387,2.9432544947996e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36299,0.151346404410633,0.0498943937737438,0.0535533926140952,0.249139416207171,0.00242741744711048
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20711.Liking for roast chicken,36299,-0.0452696097853925,0.050438165709369,-0.144128414575756,0.0535891950049708,0.369468283606046
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20712.Liking for salad dressing,36299,-0.112997618394275,0.0482700414090691,-0.20760689955605,-0.0183883372324994,0.0192624268097319
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20713.Liking for salad leaves,36299,-0.0573362744787589,0.0485511824448326,-0.152496592070631,0.0378240431131129,0.237664167043882
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20714.Liking for salami,36299,-0.294649682808512,0.0480160715094948,-0.388761182967122,-0.200538182649903,8.89085337549687e-10
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20715.Liking for salmon,36299,-0.211783251770148,0.0507550167962468,-0.311263084690792,-0.112303418849505,3.04661824894265e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20716.Liking for salty foods,36299,-0.0579951867500288,0.0477000517784729,-0.151487288235836,0.0354969147357781,0.224089871681879
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20717.Liking for salty pretzels,36299,-0.106474880555935,0.0476747020432201,-0.199917296560646,-0.0130324645512235,0.0255561145710678
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20718.Liking for sardines,36299,-0.244950525888911,0.0479124347293403,-0.338858897958418,-0.151042153819404,3.26303724963285e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20719.Liking for sausages (meat),36299,-0.0619433100992791,0.047673636419277,-0.155383637481062,0.0314970172825039,0.193876339761992
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20720.Liking for savoury biscuits,36299,-0.037279954286332,0.0481084357700693,-0.131572488395668,0.0570125798230038,0.438415637562661
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36299,-0.319221239877807,0.0484265535707881,-0.414137284876551,-0.224305194879062,4.65494142643391e-11
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20722.Liking for skimmed milk,36299,0.0478759172496787,0.0480050563561165,-0.0462139932083097,0.141965827707667,0.318648123470943
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20723.Liking for smoked fish,36299,-0.20548923178851,0.048601557665281,-0.300748284812461,-0.11023017876456,2.38696912641947e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20724.Liking for soft cheese,36299,-0.202218858195904,0.0481936697623449,-0.2966784509301,-0.107759265461708,2.75027133576576e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20725.Liking for soy sauce,36299,-0.194753070986252,0.0481257079984069,-0.289079458663129,-0.100426683309375,5.24834509074406e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20726.Liking for soya milk,36299,-0.0306328399103477,0.0481319161640399,-0.124971395591866,0.0637057157711705,0.524513410343738
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20727.Liking for spicy foods,36299,-0.247196986375025,0.0480980775671431,-0.341469218406625,-0.152924754343424,2.82922200804902e-07
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20728.Liking for spinach,36299,-0.165653595449316,0.0486633239952889,-0.261033710480082,-0.0702734804185493,0.000667561149568486
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20729.Liking for spirits,36299,-0.209796365744244,0.0480098902621313,-0.303895750658021,-0.115696980830467,1.2609864723885e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20730.Liking for strawberries,36299,-0.044717663570213,0.0527092810719767,-0.148027854471287,0.0585925273308613,0.396253264923891
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36299,0.156381071845357,0.0491665739597675,0.0600145868842123,0.252747556806501,0.00147583736282219
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20732.Liking for sweet foods,36299,0.165548583521007,0.0480180044216017,0.0714332948546675,0.259663872187346,0.000568799185520968
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20733.Liking for taking the stairs,36299,-0.298630351673611,0.049302903379889,-0.395264042298193,-0.201996661049028,1.45717075394661e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20734.Liking for tea with sugar,36299,0.231499882306897,0.058096402311214,0.117630933776918,0.345368830836877,6.82264233914568e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20735.Liking for tea without sugar,36299,-0.126932084942418,0.0499230258747228,-0.224781215656875,-0.0290829542279611,0.0110255630505169
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20736.Liking for tomato ketchup,36299,0.044550633380484,0.0477679344436726,-0.0490745181291143,0.138175784890082,0.351033852959527
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20737.Liking for tinned tuna,36299,-0.148590712186273,0.0481632176248671,-0.242990618731012,-0.0541908056415335,0.00204232963592699
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20738.Liking for turnip (white),36299,0.0191352653551801,0.0476883793915533,-0.0743339582522643,0.112604488962624,0.688243474808785
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20739.Liking for vegetables,36299,-0.00162380377577543,0.0535261052062092,-0.106534969979945,0.103287362428395,0.975799404955468
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20740.Liking for vinegar,36299,-0.126365587434131,0.0478505362283718,-0.220152638441739,-0.0325785364265219,0.00828820560677067
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20741.Liking for watching television,36299,0.153968855484484,0.0489840328184594,0.0579601511603036,0.249977559808665,0.00167774066155449
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20742.Liking for whisky,36299,-0.0968746577651957,0.0496331408642152,-0.194155613859058,0.000406298328666191,0.0509995770757488
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20743.Liking for white bread,36299,0.196647360695397,0.0474664997773304,0.103613021131829,0.289681700258964,3.46975040705771e-05
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20744.Liking for white rice,36299,0.0552934036186218,0.0484894708272848,-0.0397459592028563,0.1503327664401,0.254192437156214
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20745.Liking for white wine,36299,-0.284761659617862,0.0480217265600675,-0.378884243675595,-0.19063907556013,3.17439900616337e-09
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36299,-0.0903608970512725,0.0489239094677181,-0.186251759608,0.00552996550545498,0.0647933781655251
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20747.Liking for whole milk,36299,0.0344015857489841,0.0477510001194255,-0.0591903744850899,0.127993545983058,0.471279726258184
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20748.Liking for wholemeal bread,36299,-0.046386492379504,0.0505645770997064,-0.145493063494929,0.0527200787359205,0.358979278404556
CD300E,CMRF35-like molecule 2,Diet and food preferences,X20749.Liking for working up a sweat,36299,-0.286241429184615,0.0485784584054185,-0.381455207659235,-0.191027650709995,3.98156924949279e-09
CD300E,CMRF35-like molecule 2,Physical measures,X21001.Body mass index (BMI),52356,-0.0800448194372045,0.01467944021463,-0.108816522257879,-0.0512731166165298,5.00747796193635e-08
CD300E,CMRF35-like molecule 2,Physical measures,X21002.Weight,52375,0.0182378577397146,0.00789118366569967,0.00277113775494323,0.0337045777244859,0.0208322590410094
CD300E,CMRF35-like molecule 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,37109,0.0113665650246957,0.00528919354552882,0.000999745675459233,0.0217333843739322,0.0316633122614188
CD300E,CMRF35-like molecule 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36102,0.0431934115365602,0.0515475966267459,-0.0578398778518618,0.144226700924982,0.402097570914968
CD300E,CMRF35-like molecule 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36119,0.0772593167734752,0.0528597508353909,-0.0263457948638909,0.180864428410841,0.143898815492163
CD300E,CMRF35-like molecule 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36121,0.0028543479519741,0.0519515794240767,-0.0989707477192162,0.104679443623164,0.956185884141846
CD300E,CMRF35-like molecule 2,Health and medical history,X21040.Satisfaction with bowel habits,36074,0.0693971298532208,0.0481379916833516,-0.0249533338461483,0.16374759355259,0.149452606910308
CD300E,CMRF35-like molecule 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36057,0.127864222663965,0.0518051660581409,0.0263260971900092,0.229402348137922,0.0136046173630099
CD300E,CMRF35-like molecule 2,Health and medical history,X21042.Greatest number of times bowels opened per day,36075,-0.0695775961403984,0.0508302410113157,-0.169204868522577,0.0300496762417803,0.171099340351781
CD300E,CMRF35-like molecule 2,Health and medical history,X21043.Least number of times bowels opened per week,36008,0.0651607763014269,0.0517686773090317,-0.0363058312242752,0.166627383827129,0.208185035064482
CD300E,CMRF35-like molecule 2,Health and medical history,X21044.Average number of times bowels opened per day,36038,0.0287604062598463,0.0579953734395606,-0.0849105256816925,0.142431338201385,0.619974818872487
CD300E,CMRF35-like molecule 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36125,0.0671469291106624,0.0519847823598879,-0.0347432443147178,0.169037102536043,0.196516225323679
CD300E,CMRF35-like molecule 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36120,-0.0821166706142509,0.0522345318127125,-0.184496352967168,0.0202630117386656,0.115978536733762
CD300E,CMRF35-like molecule 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32828,0.0169146925081115,0.0923328394559672,-0.164057672825584,0.197887057841807,0.854657126467035
CD300E,CMRF35-like molecule 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36123,0.0782869438521686,0.0601160093997285,-0.0395404345712992,0.196114322275636,0.192869279998003
CD300E,CMRF35-like molecule 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36122,-0.216871402484783,0.0771231825284802,-0.368032840240604,-0.0657099647289615,0.004937095234814
CD300E,CMRF35-like molecule 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36120,-0.094590656722608,0.0600839273906356,-0.212355154408254,0.0231738409630377,0.115461753360898
CD300E,CMRF35-like molecule 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36120,-0.337013122212268,0.144262462510934,-0.619767548733697,-0.0542586956908379,0.0195138408594058
CD300E,CMRF35-like molecule 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36126,0.0359227795968525,0.0614477591623675,-0.0845148283613878,0.156360387555093,0.558831143547314
CD300E,CMRF35-like molecule 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36122,-0.288763969747958,0.0567685009443653,-0.400030231598914,-0.177497707897002,3.7393453620293e-07
CD300E,CMRF35-like molecule 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35961,0.0736533591199363,0.0545812087246179,-0.0333258099803147,0.180632528220187,0.177244996425031
CD300E,CMRF35-like molecule 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36116,-0.0509513654692071,0.0521409661579539,-0.153147659138797,0.0512449282003824,0.328511769947192
CD300E,CMRF35-like molecule 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36122,-0.204581905571015,0.0814612025282854,-0.364245862526454,-0.0449179486155754,0.0120478064430847
CD300E,CMRF35-like molecule 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36127,-0.206560431941298,0.0527634733877402,-0.309976839781269,-0.103144024101327,9.13321730971273e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36126,0.0276947070023465,0.0521275001757676,-0.0744751933421579,0.129864607346851,0.595236355262683
CD300E,CMRF35-like molecule 2,Working and living environment,X21100.Water hardness (USGS classification),52326,-0.0187764110239169,0.0259938765570214,-0.0697244090756788,0.0321715870278449,0.470092905196343
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2139.Age first had sexual intercourse,48498,-0.00247492593567552,0.00356302927542973,-0.00945846331551779,0.00450861144416675,0.487306313986441
CD300E,CMRF35-like molecule 2,Health and medical history,X2149.Lifetime number of sexual partners,47298,-0.0865277953034013,0.0303474312534732,-0.146008760560209,-0.0270468300465938,0.00435984028930454
CD300E,CMRF35-like molecule 2,Physical activities,X22032.IPAQ activity group,47303,-0.29979949875792,0.0300403631318391,-0.358678610496324,-0.240920387019515,2.14551900430702e-23
CD300E,CMRF35-like molecule 2,Physical activities,X22033.Summed days activity,47811,-0.0442137551536797,0.00349350845834587,-0.0510610317320376,-0.0373664785753217,1.46663431022076e-36
CD300E,CMRF35-like molecule 2,Physical activities,X22034.Summed minutes activity,47303,-0.0316434645016246,0.00347572772407311,-0.0384558908408079,-0.0248310381624413,9.58047291514795e-20
CD300E,CMRF35-like molecule 2,Physical activities,X22037.MET minutes per week for walking,46309,-0.0233221897413972,0.00371235051052855,-0.0305983967420331,-0.0160459827407612,3.4160164900935e-10
CD300E,CMRF35-like molecule 2,Physical activities,X22038.MET minutes per week for moderate activity,47303,-0.0249714609841135,0.00339453842705422,-0.0316247563011397,-0.0183181656670872,1.97059753301952e-13
CD300E,CMRF35-like molecule 2,Physical activities,X22039.MET minutes per week for vigorous activity,47303,-0.345469052089655,0.030414357144948,-0.405081192093753,-0.285856912085557,8.46423456281993e-30
CD300E,CMRF35-like molecule 2,Physical activities,X22040.Summed MET minutes per week for all activity,46309,-0.0338796299617941,0.00359950247814891,-0.040934654818966,-0.0268246051046223,5.45497095447784e-21
CD300E,CMRF35-like molecule 2,Eye measures,X2217.Age started wearing glasses or contact lenses,50476,-0.00318443631349521,0.0029762143014395,-0.00901781634431662,0.0026489437173262,0.284648532060951
CD300E,CMRF35-like molecule 2,Working and living environment,X22501.Year ended full time education,34176,-0.0371175501713959,0.0142592937359682,-0.0650657658938937,-0.00916933444889812,0.00926743677719748
CD300E,CMRF35-like molecule 2,Lifestyle factors,X22506.Tobacco smoking,34144,0.0195077327418033,0.121974102242644,-0.219561507653779,0.258576973137385,0.872940066871753
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,51139,-0.102466997446328,0.0995011631090556,-0.297489277140077,0.092555282247421,0.303111949331093
CD300E,CMRF35-like molecule 2,Physical measures,X23098.Weight,51878,0.0205411226265085,0.00792167466732567,0.00501464027855013,0.0360676049744668,0.00951961469794366
CD300E,CMRF35-like molecule 2,Physical measures,X23099.Body fat percentage,51871,0.0630032603849716,0.00750515820580295,0.0482931503015978,0.0777133704683454,4.94238556306076e-17
CD300E,CMRF35-like molecule 2,Physical measures,X23100.Whole body fat mass,51855,0.0552056404776794,0.00740003700343633,0.0407015679509442,0.0697097130044146,8.95088018113336e-14
CD300E,CMRF35-like molecule 2,Physical measures,X23101.Whole body fat-free mass,51877,-0.0195191058691442,0.00645296946058186,-0.0321669260118846,-0.00687128572640373,0.00249055096437973
CD300E,CMRF35-like molecule 2,Physical measures,X23102.Whole body water mass,51878,-0.0204013338789265,0.0064739281398798,-0.033090233033091,-0.00771243472476214,0.00162753010111536
CD300E,CMRF35-like molecule 2,Physical measures,X23104.Body mass index (BMI),51878,-0.068914082377594,0.0146085882868165,-0.0975469154197543,-0.0402812493354338,2.40338207127271e-06
CD300E,CMRF35-like molecule 2,Physical measures,X23105.Basal metabolic rate,51878,-0.0143953962900122,0.00689299207832073,-0.0279056607635209,-0.000885131816503617,0.0367719531356128
CD300E,CMRF35-like molecule 2,Physical measures,X23106.Impedance of whole body,51875,0.0590264013565455,0.00524583350956147,0.0487445676778051,0.069308235035286,2.70560205119177e-29
CD300E,CMRF35-like molecule 2,Physical measures,X23107.Impedance of leg (right),51878,0.00826665286866839,0.00424888166943818,-6.11552034304359e-05,0.0165944609407672,0.0517143306124534
CD300E,CMRF35-like molecule 2,Physical measures,X23108.Impedance of leg (left),51878,0.00706081774247884,0.00422306028605608,-0.00121638041819108,0.0153380159031488,0.0945446071776431
CD300E,CMRF35-like molecule 2,Physical measures,X23109.Impedance of arm (right),51875,0.081082820967828,0.00516513792636321,0.0709591506321561,0.0912064913034999,3.0456231635966e-55
CD300E,CMRF35-like molecule 2,Physical measures,X23110.Impedance of arm (left),51878,0.0804946556354722,0.00518512666782771,0.0703318073665299,0.0906575039044145,4.52061940319876e-54
CD300E,CMRF35-like molecule 2,Physical measures,X23111.Leg fat percentage (right),51878,-0.0110639670276864,0.0088444890734,-0.0283991656115504,0.00627123155617757,0.210967543472807
CD300E,CMRF35-like molecule 2,Physical measures,X23112.Leg fat mass (right),51878,0.0112483392423647,0.00969965124123034,-0.0077629771904468,0.0302596556751761,0.246197717568748
CD300E,CMRF35-like molecule 2,Physical measures,X23113.Leg fat-free mass (right),51877,0.0126590657307905,0.00656702916138095,-0.000212311425516157,0.0255304428870972,0.0539086445033007
CD300E,CMRF35-like molecule 2,Physical measures,X23114.Leg predicted mass (right),51877,0.0135653325801072,0.0066077050423622,0.000614230697077261,0.0265164344631371,0.0400882181676292
CD300E,CMRF35-like molecule 2,Physical measures,X23115.Leg fat percentage (left),51875,-0.0215891934052689,0.00929585667202678,-0.0398090724824414,-0.00336931432809645,0.0202173424427864
CD300E,CMRF35-like molecule 2,Physical measures,X23116.Leg fat mass (left),51875,0.00763166428535839,0.0101528175969936,-0.0122678582047491,0.0275311867754659,0.452251654771684
CD300E,CMRF35-like molecule 2,Physical measures,X23117.Leg fat-free mass (left),51874,0.0155876672166702,0.00691595548783789,0.00203239446050795,0.0291429399728325,0.0242138295821345
CD300E,CMRF35-like molecule 2,Physical measures,X23118.Leg predicted mass (left),51874,0.0167616852580521,0.00695914343249927,0.00312176413035355,0.0304016063857507,0.0160224400507588
CD300E,CMRF35-like molecule 2,Physical measures,X23119.Arm fat percentage (right),51874,0.0912743007048164,0.00849053924632387,0.0746328437820216,0.107915757627611,6.87122247414667e-27
CD300E,CMRF35-like molecule 2,Physical measures,X23120.Arm fat mass (right),51872,0.0614829551602184,0.00848365408349113,0.0448549931565758,0.078110917163861,4.39012959199183e-13
CD300E,CMRF35-like molecule 2,Physical measures,X23121.Arm fat-free mass (right),51873,-0.0419653584496965,0.00659141947528029,-0.0548845406212458,-0.0290461762781471,1.96883147311162e-10
CD300E,CMRF35-like molecule 2,Physical measures,X23122.Arm predicted mass (right),51873,-0.0419493948966563,0.00660714094372712,-0.0548993911463615,-0.0289993986469511,2.20682672314742e-10
CD300E,CMRF35-like molecule 2,Physical measures,X23123.Arm fat percentage (left),51872,0.0956332306598289,0.00869270735938154,0.0785955242354411,0.112670937084217,4.42383503756666e-28
CD300E,CMRF35-like molecule 2,Physical measures,X23124.Arm fat mass (left),51872,0.0608480552796903,0.00849490878389966,0.044198034063247,0.0774980764961337,8.14101990584892e-13
CD300E,CMRF35-like molecule 2,Physical measures,X23125.Arm fat-free mass (left),51872,-0.0392727647669291,0.00672320434614649,-0.0524502452853762,-0.026095284248482,5.24784571989561e-09
CD300E,CMRF35-like molecule 2,Physical measures,X23126.Arm predicted mass (left),51870,-0.0386040905317298,0.00672810441861046,-0.0517911751922063,-0.0254170058712533,9.7172101123629e-09
CD300E,CMRF35-like molecule 2,Physical measures,X23127.Trunk fat percentage,51869,0.0561455962105386,0.00537214517254219,0.0456161916723559,0.0666750007487213,1.65273415695515e-25
CD300E,CMRF35-like molecule 2,Physical measures,X23128.Trunk fat mass,51869,0.0544393758235716,0.00601101041676775,0.0426577954067068,0.0662209562404364,1.45163544835599e-19
CD300E,CMRF35-like molecule 2,Physical measures,X23129.Trunk fat-free mass,51868,-0.0303058114444572,0.00582120662398602,-0.0417153764274698,-0.0188962464614446,1.94527388464668e-07
CD300E,CMRF35-like molecule 2,Physical measures,X23130.Trunk predicted mass,51865,-0.029652153268907,0.00583855672044087,-0.0410957244409711,-0.0182085820968429,3.8307988618036e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23400.Total Cholesterol,42677,-0.0561316154671546,0.00424541952855121,-0.064452637743115,-0.0478105931911942,1.16091268830876e-39
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42677,-0.0352770845646581,0.00413489695189492,-0.0433814825903722,-0.0271726865389441,1.59674011137492e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42677,-0.0213444038023264,0.00413821574599976,-0.029455306664486,-0.0132335009401669,2.53307793106391e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23403.VLDL Cholesterol,42677,0.00757052603126895,0.00421193062482377,-0.000684857993385631,0.0158259100559235,0.0722944359233744
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,42677,-0.0467884340090723,0.00412017833495265,-0.0548639835455795,-0.0387128844725651,9.45970665385199e-30
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23405.LDL Cholesterol,42677,-0.0468897389312113,0.00414128174296521,-0.0550066511474231,-0.0387728267149995,1.38064467016945e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23406.HDL Cholesterol,42677,-0.0979996095013519,0.00470018281262921,-0.107211967814105,-0.0887872511885986,4.7677683409721e-95
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23407.Total Triglycerides,42677,0.0267315920213408,0.00454330351298383,0.0178267171358925,0.0356364669067891,4.1062819387296e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23408.Triglycerides in VLDL,42677,0.0223303395309985,0.0045290853254435,0.0134533322931292,0.0312073467688677,8.30251402133733e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23409.Triglycerides in LDL,42677,0.0369938984210725,0.00449994648948811,0.0281740033016757,0.0458137935404692,2.20200026150252e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23410.Triglycerides in HDL,42677,0.029410597442926,0.00444631270119111,0.0206958245485914,0.0381253703372605,3.86599116884421e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42677,-0.0568002465632914,0.00440507513114431,-0.0654341938203342,-0.0481662993062485,8.1097705043266e-38
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23412.Phospholipids in VLDL,42677,0.018847609821628,0.00434413959178539,0.0103330962217286,0.0273621234215274,1.44417375663941e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23413.Phospholipids in LDL,42677,-0.0426560314927891,0.00412010289365737,-0.0507314331643575,-0.0345806298212207,5.02510844448845e-25
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23414.Phospholipids in HDL,42677,-0.0824303826697915,0.00469200130908128,-0.0916267052355908,-0.0732340601039922,2.48336240255431e-68
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23415.Total Esterified Cholesterol,42677,-0.061388839070147,0.00426068318194691,-0.0697397781067629,-0.053037900033531,1.0210541750984e-46
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42677,0.00438550238660919,0.00416299239718279,-0.00377396271186908,0.0125449674850875,0.292153891447942
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42677,-0.043879863247504,0.00414988358644559,-0.0520136350769373,-0.0357460914180706,4.98649728068947e-26
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42677,-0.100393400903416,0.00467073799903459,-0.109548047381524,-0.0912387544253084,8.61124368857277e-101
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23419.Total Free Cholesterol,42677,-0.0424613402556111,0.00420969555156599,-0.0507123435366804,-0.0342103369745417,7.69693141495623e-24
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,42677,0.0118320000207069,0.00429622002317442,0.00341140877528505,0.0202525912661288,0.00589418434734514
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23421.Free Cholesterol in LDL,42677,-0.0533647750717942,0.00413964168796403,-0.0614784727802037,-0.0452510773633847,8.4400846950482e-38
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23422.Free Cholesterol in HDL,42677,-0.082234633255909,0.00477322384567932,-0.0915901519934405,-0.0728791145183775,8.2335112679299e-66
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42677,-0.0401994907613386,0.00425415124772039,-0.0485376272068705,-0.0318613543158066,3.95835485145651e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23424.Total Lipids in VLDL,42677,0.0175025200639893,0.00440300869476944,0.0088726230222412,0.0261324171057374,7.07083229010961e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23425.Total Lipids in LDL,42677,-0.0423156656596965,0.00414275603160868,-0.0504354674816495,-0.0341958638377435,2.09802211263249e-24
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23426.Total Lipids in HDL,42677,-0.08745863905301,0.00471123834130001,-0.096692666201958,-0.0782246119040619,5.56479808493975e-76
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42677,-0.0976381415834113,0.00442110715290096,-0.106303511603097,-0.0889727715637255,3.36229214955814e-106
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23428.Concentration of VLDL Particles,42677,0.0162998293411171,0.00428558909765387,0.00790007470971547,0.0246995839725187,0.000143350567964762
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23429.Concentration of LDL Particles,42677,-0.0190341607126902,0.00412279007318797,-0.0271148292561386,-0.0109534921692417,3.93271853234733e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23430.Concentration of HDL Particles,42677,-0.100401153498116,0.00442557456087333,-0.109075279637427,-0.0917270273588038,7.45161630775925e-112
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42677,0.00912089608615055,0.00461511605540644,7.52686175539193e-05,0.0181665235547472,0.0481401227610983
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,42677,-0.00847422862654059,0.00439052771957929,-0.017079662956916,0.000131205703834807,0.0536133924997681
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,42677,-0.0319800065560754,0.00493600433015246,-0.0416545750431743,-0.0223054380689766,9.55862687235921e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23434.Phosphoglycerides,42666,-0.062478818736251,0.00448433340070559,-0.071268112201634,-0.053689525270868,8.07274172727241e-44
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42666,0.0632028502843413,0.00469502441632235,0.0540006024283495,0.0724050981403331,4.84203967643842e-41
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23436.Total Cholines,42666,-0.0650629342477706,0.00448679176653404,-0.0738570461101773,-0.0562688223853639,2.71074122445473e-47
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23437.Phosphatidylcholines,42666,-0.0683659548512524,0.00451755393257492,-0.0772203605590993,-0.0595115491434056,2.57473755520517e-51
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23438.Sphingomyelins,42666,-0.0518881319239431,0.00441600025893393,-0.0605434924314536,-0.0432327714164326,1.00822067005639e-31
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23439.Apolipoprotein B,42677,-0.0168407234982348,0.00412162185049463,-0.0249191023252043,-0.00876234467126532,4.41516504276159e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23440.Apolipoprotein A1,42677,-0.0909608796643149,0.00458987164069624,-0.0999570280800795,-0.0819647312485502,3.51146512237962e-86
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42677,0.0282126682370089,0.00421974897916556,0.0199419602378444,0.0364833762361734,2.38602177133914e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23442.Total Fatty Acids,42666,-0.0122555972798377,0.00439432167236102,-0.0208684677576653,-0.00364272680201015,0.00529514279315285
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23443.Degree of Unsaturation,42666,-0.0786891134596069,0.00441158454957316,-0.0873358191767703,-0.0700424077424435,2.34850442416754e-70
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,42666,-0.0661607503838836,0.00439388088803822,-0.0747727569244385,-0.0575487438433287,7.98628558185059e-51
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,42666,-0.0296939401745563,0.00432503339548819,-0.0381710056297131,-0.0212168747193994,6.91133082823433e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42666,-0.0433889569124655,0.00437500844892285,-0.0519639734723543,-0.0348139403525767,4.19437392390247e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42666,0.0269863382454819,0.00449737075682495,0.018171491562105,0.0358011849288589,2.01795286739524e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23448.Saturated Fatty Acids,42666,-0.0156783609425168,0.00439306781470185,-0.0242887738593325,-0.00706794802570121,0.00035974765667366
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23449.Linoleic Acid,42666,-0.016691481187328,0.00424192866139559,-0.0250056613636634,-0.00837730101099265,8.36560621119227e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23450.Docosahexaenoic Acid,42666,-0.0851144476977305,0.0043620636254281,-0.0936640924035696,-0.0765648029918914,1.22384605617956e-83
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42666,-0.0716577363319497,0.00433837663143682,-0.0801609545295659,-0.0631545181343335,1.08929213181536e-60
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42666,-0.0245116711284329,0.00470697584544753,-0.0337373437855101,-0.0152859984713557,1.94199646587794e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42666,-0.0577582577970068,0.0046237655119648,-0.0668208382004578,-0.0486956773935558,1.30646665311221e-35
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42666,0.0973242982153379,0.00463750080895504,0.088234796629786,0.10641379980089,3.00879289220535e-96
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42666,-0.0176973459776275,0.00427115995103372,-0.0260688194816536,-0.00932587247360138,3.44206376457321e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42666,-0.0103788092322428,0.00452643031175774,-0.019250612643288,-0.00150700582119765,0.0218670963910911
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42666,-0.0785908631936683,0.00431892649619826,-0.0870559591262168,-0.0701257672611197,4.09606418745565e-73
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42666,-0.0836380259172231,0.00466575140722567,-0.0927828986753854,-0.0744931531590607,4.93615743462497e-71
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42666,0.0590396825855509,0.00430674992167952,0.050598452739059,0.0674809124320427,1.73732980866849e-42
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23460.Alanine,42671,-0.0103311404277358,0.00427924157544734,-0.0187184539156126,-0.00194382693985901,0.0157810643469369
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23461.Glutamine,42635,-0.0220194572626935,0.00429413940105157,-0.0304359704887546,-0.0136029440366324,2.9723415925031e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23462.Glycine,42661,0.0219365002476335,0.00455777677392566,0.0130032577707392,0.0308697427245278,1.50308206981633e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23463.Histidine,42658,-0.0327447002374323,0.00421758005333982,-0.0410111571419784,-0.0244782433328863,8.83105662408014e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42667,-0.0206780811257275,0.00446892278947522,-0.0294371697930989,-0.0119189924583561,3.74306554529007e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23465.Isoleucine,42673,-0.00381156439641236,0.00435390271107739,-0.012345213710124,0.00472208491729932,0.381352165622966
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23466.Leucine,42673,-0.0203613215808211,0.00440607647978095,-0.0289972314811917,-0.0117254116804504,3.85080142936251e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23467.Valine,42667,-0.0256244607744799,0.00451221054989143,-0.0344683934522671,-0.0167805280966927,1.38352133086553e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23468.Phenylalanine,42670,0.0475845479911427,0.00425395412745215,0.0392467979013365,0.0559222980809489,6.40532821325543e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23469.Tyrosine,42661,-0.0141837228618556,0.00434198376252578,-0.0226940110364061,-0.00567343468730503,0.00109102014670196
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23470.Glucose,42650,-0.0208248774148258,0.00422073993371896,-0.029097527684915,-0.0125522271447367,8.15508680592865e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23471.Lactate,42652,0.0272384765821861,0.0042260835949679,0.018955352736049,0.0355216004283232,1.1928591582428e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23472.Pyruvate,42638,0.0303203598874823,0.0042752401703482,0.0219408891535999,0.0386998306213648,1.3871160158821e-12
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23473.Citrate,42674,0.0363503628622562,0.00428279664947289,0.0279560814292893,0.044744644295223,2.32937512599452e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23474.3-Hydroxybutyrate,42451,0.0406562177276221,0.00449342364018424,0.031849107392861,0.0494633280623832,1.65742229081386e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23475.Acetate,42665,-0.0309842493743461,0.00420797817024583,-0.0392318865880279,-0.0227366121606643,1.89948682935117e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23476.Acetoacetate,42675,0.00120473316274879,0.00432881008679023,-0.00727973460736007,0.00968920093285764,0.780781855514124
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23477.Acetone,42675,-0.0133461868593477,0.00429239616313414,-0.0217592833390906,-0.00493309037960474,0.00187945651917453
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23478.Creatinine,42362,0.183389419184437,0.004546135483391,0.17447899363699,0.192299844731883,0
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23479.Albumin,42675,-0.0966150948701369,0.00421343635825659,-0.10487343013232,-0.088356759607954,3.50127026990044e-114
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23480.Glycoprotein Acetyls,42677,0.11984404313937,0.00441427665419257,0.111192060897153,0.128496025381588,4.42847092263204e-158
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42677,0.0376429010890534,0.0045579386147502,0.028709341404143,0.0465764607739638,1.60816227331805e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42677,0.0341201756979758,0.00450766914036961,0.0252851441828514,0.0429552072131002,3.99373537817888e-14
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42677,0.0397132359759631,0.0045676737073664,0.0307605955095249,0.0486658764424012,3.88522964300961e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42677,0.0386487498361748,0.00452278840444651,0.0297840845634596,0.04751341510889,1.41810989467687e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42677,0.0375596728587554,0.00447039635446851,0.0287976960039972,0.0463216497135137,4.83071996039923e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42677,0.038759348475973,0.00456461321339717,0.0298127065777146,0.0477059903742315,2.25599974543404e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42677,0.0288657836106067,0.00446935322166006,0.020105851296153,0.0376257159250605,1.09297763009825e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42677,0.0262606773313264,0.00454686367658776,0.0173488245252144,0.0351725301374384,7.83900201456696e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42677,0.0239333711785688,0.00452462084825774,0.0150651143159836,0.0328016280411539,1.24510744195227e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42677,0.0279723118041155,0.00450998695410901,0.0191327373740618,0.0368118862341691,5.72678968067935e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42677,0.0225475360730958,0.00440833681800268,0.0139071959098105,0.031187876236381,3.18469285381529e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42677,0.0185218632122425,0.0043394750746909,0.0100164920658483,0.0270272343586366,1.98379565580321e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42677,0.0266553112971397,0.00447509086190707,0.0178841332078018,0.0354264893864776,2.64319158070175e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42677,0.0227711820470287,0.00455183173649898,0.0138495918434907,0.0316927722505667,5.72620665840534e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42677,0.0215266009082423,0.00449362546282372,0.0127190950011078,0.0303341068153768,1.68158343724037e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,42677,0.0157486478176583,0.00447081193356945,0.00698585642786218,0.0245114392074544,0.000428833958430807
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,42677,0.026227342193356,0.00448951495611956,0.0174278928793616,0.0350267915073503,5.27962746599149e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,42677,0.0208013158801626,0.00440127258079521,0.012174821621804,0.0294278101385212,2.31066645408955e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42677,0.0198083711175725,0.00432418444506828,0.0113329696052387,0.0282837726299063,4.67275046012751e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42677,0.0212822042509355,0.00448232871403904,0.012496839971419,0.030067568530452,2.07526790341566e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,42677,0.00787035655907733,0.00446738747589113,-0.000885722893669279,0.0166264360118239,0.0781366015061776
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42677,-0.0040732055020479,0.00421492811255018,-0.0123344646026463,0.00418805359855045,0.333873386135319
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42677,-0.00197636316761081,0.0042622431096627,-0.0103303596625497,0.00637763332732808,0.642876732716069
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42677,-0.00415306252812688,0.00419710994188253,-0.0123793980142166,0.00407327295796289,0.322433735230938
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42677,-0.0164248044530773,0.00411730305213887,-0.0244947184352695,-0.00835489047088512,6.66427546050496e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42677,-0.0217632767960629,0.00412749049120175,-0.0298531581588183,-0.0136733954333075,1.3646118822117e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42677,-0.00840265721032607,0.00416612393982028,-0.0165682601323738,-0.000237054288278318,0.043725687032187
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42677,0.00911700133092668,0.00442751281391628,0.00043907621565077,0.0177949264462026,0.0394971215297538
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42677,0.0263232535374678,0.00434771307368297,0.0178017359130492,0.0348447711618865,1.44590357061244e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,42677,0.0207735865389028,0.00433755501809663,0.0122719787034335,0.0292751943743722,1.69195854567515e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,42677,0.00564531045294517,0.00423653218613932,-0.00265829263188789,0.0139489135377782,0.182708282178746
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,42677,0.00884803660739215,0.00419582030957446,0.000624228800626203,0.0170718444141581,0.0349824907544125
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42677,0.0173224242426017,0.00421629266681075,0.00905849061565264,0.0255863578695508,4.00678454971331e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42677,-0.00568268831819999,0.00416288895308505,-0.0138419506662467,0.00247657402984671,0.172249788212721
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,42677,0.0367456950389064,0.00449509330034781,0.0279353121702247,0.0455560779075881,3.23115903679619e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42677,0.017486422925254,0.00423625729883632,0.00918335861953485,0.0257894872309732,3.68453609294883e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42677,0.0190863250379981,0.00427712411079393,0.010703161780842,0.0274694882951542,8.16957471138159e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42677,0.0315988901454281,0.00427570058950048,0.0232185169900072,0.0399792633008491,1.55067668275453e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42677,-0.00391194263303391,0.00422042928812554,-0.01218398403776,0.00436009877169215,0.353991760122591
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42677,-0.0124611405042894,0.00422345814708581,-0.0207391184725776,-0.00418316253600124,0.00317847650724035
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42677,0.0162182943032527,0.00424324975298789,0.00790152478739642,0.0245350638191089,0.000132893125806409
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42677,0.0540964380690315,0.0044781993396566,0.0453191673633046,0.0628737087747584,2.00565236652469e-33
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23523.Concentration of IDL Particles,42677,-0.0242524863353069,0.00409698514369266,-0.0322825772169445,-0.0162223954536693,3.30581559892138e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23524.Total Lipids in IDL,42677,-0.0409844898929161,0.00420760795244321,-0.0492314014797048,-0.0327375783061275,2.39839557142601e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23525.Phospholipids in IDL,42677,-0.0304893955952157,0.00422447214249295,-0.0387693609945019,-0.0222094301959295,5.58546577187059e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23526.Cholesterol in IDL,42677,-0.0507230832214911,0.00419587483711483,-0.0589469979022362,-0.042499168540746,1.8031149196647e-33
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42677,-0.0535509904589097,0.00419623893910106,-0.0617756187795478,-0.0453263621382716,4.39815810407823e-37
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23528.Free Cholesterol in IDL,42677,-0.0416116451384713,0.00419256872130374,-0.0498290798322266,-0.033394210444716,3.88688841033476e-23
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23529.Triglycerides in IDL,42677,0.0475066700022001,0.0044855367007941,0.0387150180686436,0.0562983219357565,4.15102283681413e-26
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,42677,-0.0172087229683483,0.00412294174952465,-0.0252896887974166,-0.00912775713928,3.01315827756262e-05
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23531.Total Lipids in Large LDL,42677,-0.0469672099899892,0.0041622698915538,-0.0551252589774346,-0.0388091610025437,2.13133454570828e-29
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23532.Phospholipids in Large LDL,42677,-0.0481914360397057,0.00412993950349878,-0.0562861174665633,-0.040096754612848,2.60190724834942e-31
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23533.Cholesterol in Large LDL,42677,-0.0512812971080127,0.00416624992032797,-0.0594471469518555,-0.0431154472641699,1.24700094903495e-34
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42677,-0.0493497077431135,0.00416856999428121,-0.0575201049319047,-0.0411793105543223,3.56124492360345e-32
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42677,-0.0552816833512868,0.00416754273575441,-0.0634500671133654,-0.0471132995892081,6.58513404879277e-40
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23536.Triglycerides in Large LDL,42677,0.0365945500971031,0.0044898900503158,0.0277943655984841,0.0453947345957221,3.94396830490484e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42677,-0.0257254692993592,0.00414637889960923,-0.0338523719425932,-0.0175985666561251,5.65401708526146e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,42677,-0.0363476830633994,0.00416163288286753,-0.0445044835138197,-0.028190882612979,2.74496455316621e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,42677,-0.0375376436215388,0.00415152062663641,-0.0456746240497461,-0.0294006631933314,1.74721178026733e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,42677,-0.040005776162184,0.00414965091105888,-0.0481390919478594,-0.0318724603765086,6.33038309740948e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42677,-0.0351263913180099,0.00417563659636595,-0.0433106390468872,-0.0269421435891327,4.4245908307837e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42677,-0.0509102086324786,0.00412581734459351,-0.0589968106278818,-0.0428236066370753,8.55904678091835e-35
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,42677,0.0357973752527205,0.00450842612980121,0.0269608600383101,0.0446338904671309,2.17915308323512e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,42677,-0.0119880666094879,0.00412829472588626,-0.020079524272225,-0.00389660894675082,0.00369169183663291
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23545.Total Lipids in Small LDL,42677,-0.0272287544408293,0.00412580472439057,-0.0353153317006348,-0.0191421771810237,4.27612790735747e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23546.Phospholipids in Small LDL,42677,-0.0243430237877525,0.00409628042934546,-0.0323717334292696,-0.0163143141462354,2.87259176223692e-09
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23547.Cholesterol in Small LDL,42677,-0.033127988420753,0.00412116380489467,-0.0412054694783466,-0.0250505073631595,9.84722776268933e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42677,-0.0276034950589963,0.00415047687509496,-0.0357384297341824,-0.0194685603838102,3.02985777342557e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42677,-0.0441245223663091,0.00410026974270891,-0.0521610510620185,-0.0360879936705996,6.73658126902188e-27
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23550.Triglycerides in Small LDL,42677,0.0380828353115913,0.00453382712574369,0.0291965341451336,0.0469691364780489,4.91976536131612e-17
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42677,-0.0148400503097538,0.00473835460099898,-0.0241272253277118,-0.00555287529179577,0.00174050852536068
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42677,-0.0126927723487004,0.0047648813937138,-0.0220319398803795,-0.00335360481702139,0.00773514238899433
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42677,-0.00812492061028192,0.00479795252362887,-0.0175289075565945,0.00127906633603067,0.0903997660664156
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42677,-0.0226669788385407,0.00470924528931197,-0.0318970996055922,-0.0134368580714893,1.50073072093657e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42677,-0.0298905006656568,0.00475307322582538,-0.0392065241882745,-0.020574477143039,3.30081782681176e-10
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42677,0.00109160675556132,0.00451304587359195,-0.00775396315667889,0.00993717666780153,0.808878333840263
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42677,0.0398146511682223,0.00442003971108896,0.0311513733344879,0.0484779290019566,2.38210255320178e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,42677,-0.0598424991646985,0.00491803764116806,-0.069481852941388,-0.0502031453880092,6.9306284310878e-34
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23559.Total Lipids in Large HDL,42677,-0.0608260348850556,0.00492584384288445,-0.0704806888171091,-0.0511713809530021,7.67027310625859e-35
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23560.Phospholipids in Large HDL,42677,-0.0621635682748002,0.00492142382740256,-0.0718095589765092,-0.0525175775730912,2.28252489500703e-36
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23561.Cholesterol in Large HDL,42677,-0.0618201957600608,0.00487127268186337,-0.071367890216513,-0.0522725013036086,1.07848097089134e-36
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42677,-0.0635770743672626,0.00486009011967363,-0.0731028510018229,-0.0540512977327022,7.24624640419035e-39
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42677,-0.0536980185332095,0.00488960785045798,-0.0632816499201071,-0.0441143871463118,6.12150114280142e-28
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23564.Triglycerides in Large HDL,42677,0.0229857457266852,0.00457164432212889,0.0140253228553126,0.0319461685980578,5.02261097313543e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42677,-0.0914069099697024,0.00455126265594599,-0.100327384775357,-0.0824864351640482,1.99629681239966e-88
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,42677,-0.0878797273331614,0.00451936241347812,-0.0967376776635786,-0.0790217770027443,4.38250224066583e-83
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,42677,-0.081838115346265,0.0045047373550322,-0.0906674005621281,-0.0730088301304019,6.94199110702693e-73
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,42677,-0.0992962483121964,0.00452556278398668,-0.10816635136881,-0.0904261452555825,7.11646016713315e-105
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42677,-0.0999301940725179,0.00450044387460239,-0.108751064066739,-0.0911093240782972,2.57659108578716e-107
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42677,-0.092548916892312,0.00461834936266885,-0.101600881643143,-0.0834969521414811,4.75697159577902e-88
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,42677,0.0209593082339201,0.00443109606806634,0.0122743599405101,0.0296442565273301,2.26739520416085e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,42677,-0.0867629596867291,0.00418077008657196,-0.0949572690564102,-0.0785686503170481,3.40396258587466e-94
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23573.Total Lipids in Small HDL,42677,-0.0761814726347148,0.0042292734741073,-0.0844708486439651,-0.0678920966254644,1.06662354820382e-71
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23574.Phospholipids in Small HDL,42677,-0.0738886166717639,0.00425726149387353,-0.082232849199756,-0.0655443841437717,9.44360298730272e-67
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23575.Cholesterol in Small HDL,42677,-0.0926251197383893,0.0041669099282425,-0.100792263197745,-0.084457976279034,1.531917815877e-107
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42677,-0.0943999705656179,0.00414182889696271,-0.102517955203665,-0.086281985927571,7.39713375517131e-113
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42677,-0.0733189988230346,0.00430116188616002,-0.0817492761199082,-0.0648887215261609,1.7608892059634e-64
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23578.Triglycerides in Small HDL,42677,0.036226960131985,0.00450618288676334,0.0273948416739288,0.0450590785900411,9.77659356513362e-16
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42182,0.044944022176643,0.00432657407139072,0.0364639369967172,0.0534241073565688,3.53216567072001e-25
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42182,0.00430893405182833,0.00447662067510484,-0.00446524247137716,0.0130831105750338,0.335795489154398
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42182,0.00457430828724349,0.00443169993790954,-0.00411182359105921,0.0132604401655462,0.302007418656105
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42182,0.00255571903885076,0.00449524141441136,-0.00625495413339552,0.011366392211097,0.569679015369422
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,42182,-0.0164975016836602,0.00444255453622694,-0.025204908574665,-0.00779009479265539,0.000205254209480811
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42557,0.040352098174739,0.0043085890882022,0.0319072635618626,0.0487969327876153,8.76371249526674e-21
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42557,-0.0162173643124374,0.00452308058599397,-0.0250826022609856,-0.00735212636388927,0.000337672994110797
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42557,-0.0225182933587571,0.00452682671137767,-0.0313908737130574,-0.0136457130044569,6.62599740410088e-07
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42557,0.00850489297650035,0.00446529017134765,-0.000247075759341037,0.0172568617123417,0.0568447583464925
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42557,0.00476481838641482,0.0044370625320293,-0.00393182417636261,0.0134614609491922,0.282901347006479
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42676,0.0735319351124665,0.00437537629000021,0.0649561975840661,0.0821076726408669,9.60881440414613e-63
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42676,0.013500206318611,0.00428909634340738,0.00509357748553258,0.0219068351516895,0.0016499564892571
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42676,0.00439977685195165,0.00441687068600233,-0.00425728969261292,0.0130568433965162,0.319204922885899
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42676,0.0363457671261302,0.00422450398714524,0.0280657393113256,0.0446257949409349,8.5747821730901e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42676,-0.0406963276179649,0.00420465362602345,-0.0489374487249708,-0.0324552065109589,4.37465523895897e-22
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42677,-0.0151609049736043,0.00428106091704354,-0.0235517843710096,-0.00677002557619894,0.000399368218757498
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42677,-0.0329332315734804,0.00443624057971156,-0.041628263109715,-0.0242382000372457,1.20734580498165e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42677,-0.0356706209354879,0.00448175976056597,-0.0444548700661972,-0.0268863718047786,1.87124142257352e-15
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42677,-0.0243860643626031,0.00433269790656987,-0.0328781522594801,-0.0158939764657262,1.85537463906368e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42677,0.0292150750777618,0.00439767337385663,0.0205956352650028,0.0378345148905208,3.18501257718454e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42677,-0.0576813629405265,0.00440160862198271,-0.0663085158396126,-0.0490542100414404,5.36267659875835e-39
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42677,-0.0288422851478602,0.00430954885131812,-0.0372890008964437,-0.0203955693992767,2.27832771163796e-11
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42677,-0.00398428255832409,0.00423604164334423,-0.0122869241792788,0.0043183590626306,0.346943459051645
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42677,-0.0589071789544577,0.00441862430680633,-0.0675676825957981,-0.0502466753131173,2.72848754641392e-40
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42677,0.038034011267132,0.00434220907394602,0.0295232814821978,0.0465447410520663,2.19966580993728e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42677,0.107038235483364,0.00423557420687896,0.098736510037881,0.115339960928847,1.03470577558217e-137
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42677,-0.0680244430878685,0.00444572040291139,-0.0767380550775748,-0.0593108310981621,2.07067514869723e-52
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42677,-0.0738604857651971,0.00447621181628106,-0.082633860925108,-0.0650871106052862,1.42268392573279e-60
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42677,-0.0133512316553203,0.00424935558460927,-0.0216799686011544,-0.00502249470948612,0.00168194156494671
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42677,0.0523693595132861,0.00444247932602567,0.0436621000342757,0.0610766189922964,6.4318469456375e-32
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42677,0.078904753409297,0.00403172655772161,0.0710025693561627,0.0868069374624314,4.00385160763204e-84
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42677,-0.0905388148404073,0.00425230491534783,-0.0988733324744891,-0.0822042972063256,5.72658531887274e-99
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42677,-0.0974213570425153,0.00423457831846188,-0.105721130546701,-0.08912158353833,6.51312072875193e-115
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42677,-0.0224607564799145,0.00415494046604351,-0.0306044397933597,-0.0143170731664692,6.56198675227733e-08
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42677,0.0857806954450307,0.00439672139826117,0.0771631215044388,0.0943982693856226,1.27530448506829e-83
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42677,-0.00352362740767319,0.00414504336059345,-0.0116479123944364,0.00460065757908997,0.395294504746935
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42677,-0.0932172213200458,0.00441232163118893,-0.101865371717176,-0.0845690709229155,1.71037348254435e-97
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42677,-0.0561020374292176,0.00415857667039522,-0.0642528477031922,-0.047951227155243,3.28348651542327e-41
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42677,-0.064506075221258,0.00444742670144425,-0.0732230315560888,-0.0557891188864273,2.58954629119558e-47
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42677,0.0920695631791383,0.00440097804855825,0.0834436462039641,0.100695480154312,1.15126278232799e-95
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42677,-0.00219637429461613,0.00424630582019575,-0.0105191337021998,0.00612638511296754,0.604994639895354
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42677,-0.0701497174247322,0.00409475381640884,-0.0781754349048935,-0.0621239999445709,4.20819261545187e-65
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42677,-0.0127184633630714,0.00428363603925775,-0.0211143900000166,-0.00432253672612626,0.00299217130827406
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42677,-0.0618565837944436,0.00454702958795108,-0.0707687617868277,-0.0529444058020595,7.18771201642183e-42
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42677,0.0853158745956834,0.00433267397310386,0.0768238336083998,0.0938079155829669,4.00524418033517e-85
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42677,0.0201917835334078,0.0042026628734447,0.0119545643014562,0.0284290027653594,1.56792469915022e-06
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42677,-0.0661105965238747,0.00418926842640957,-0.0743215626396375,-0.057899630408112,1.32272984126012e-55
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42677,-0.0163643675028112,0.00420542430854815,-0.0246069991475655,-0.0081217358580568,0.000100207687649688
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42677,-0.0645436379097798,0.00445519738328623,-0.0732758247810209,-0.0558114510385388,3.29814398728124e-47
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42677,0.0706625510631787,0.00444287829285882,0.0619545096091754,0.079370592517182,1.91582343665831e-56
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42668,0.0102008365564209,0.00468275612927012,0.00102263454305148,0.0193790385697903,0.0293948064213633
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42668,-0.0385452208341981,0.00440949691326116,-0.04718783478419,-0.0299026068842062,2.57177819377314e-18
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42668,-0.0768322945218791,0.00424020618215739,-0.0851430986389075,-0.0685214904048506,1.60709451036898e-72
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42668,0.035229516645476,0.00488707111012375,0.0256508572696335,0.0448081760213186,5.94890160819471e-13
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42668,0.041618936438061,0.00465358081542936,0.0324979180398195,0.0507399548363026,4.25907873424376e-19
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42677,0.0107467449309413,0.00454581533985291,0.00183694686482961,0.019656542997053,0.018088209974967
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42677,-0.0495744464720471,0.00467495868184208,-0.0587373654884576,-0.0404115274556366,3.6098645715527e-26
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42677,-0.0551837043865037,0.00470214717240167,-0.064399912844411,-0.0459674959285964,1.189900997234e-31
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42677,-0.0105399780654364,0.00445974944398885,-0.0192810869756545,-0.00179886915521823,0.0181243421410085
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42677,0.0717044229225046,0.00459659933377452,0.0626950882283065,0.0807137576167026,2.19226751577292e-54
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42677,0.0778170926615406,0.00456805641218034,0.0688637020936671,0.0867704832294141,2.12642481216625e-64
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42677,-0.0824247717463204,0.00451927988015166,-0.0912825603114177,-0.0735669831812232,1.94668688969813e-73
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42677,-0.0740982824774686,0.0045016437631353,-0.0829215042532138,-0.0652750607017234,2.73881541294033e-60
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42677,-0.0824013933869565,0.00473724530344447,-0.0916863941817077,-0.0731163925922054,4.90113349271373e-67
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42677,0.0786157935385048,0.00446059147663627,0.0698730342442977,0.0873585528327119,9.40850442910697e-69
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42677,0.0104752518717429,0.00442428440121587,0.00180365444535977,0.019146849298126,0.0179144554245848
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42677,-0.0636963252844435,0.00438172461864128,-0.0722845055369804,-0.0551081450319066,1.61937672354762e-47
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42677,-0.0659966450074322,0.00442356742546435,-0.0746668371613423,-0.0573264528535221,6.17216311243021e-50
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42677,0.0019833984644831,0.00441180101795191,-0.00666373153070264,0.0106305284596688,0.653030189267529
CD300E,CMRF35-like molecule 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42677,0.0846753969321156,0.00449802973998494,0.0758592586417451,0.0934915352224861,4.70737121315353e-78
CD300E,CMRF35-like molecule 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52186,-0.000148082015747073,0.00359719338718339,-0.00719858105462652,0.00690241702313238,0.967163926663931
CD300E,CMRF35-like molecule 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52186,0.00103422032834618,0.00350389357637882,-0.00583341108135631,0.00790185173804867,0.767871902015933
CD300E,CMRF35-like molecule 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50724,0.00315282715103665,0.00333785787750245,-0.00338937428886815,0.00969502859094146,0.344891078257895
CD300E,CMRF35-like molecule 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50724,0.00310292456293594,0.00366752824692336,-0.00408543080103384,0.0102912799269057,0.39753238556617
CD300E,CMRF35-like molecule 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50724,-0.000774903693561718,0.00357489356756745,-0.00778169508599393,0.00623188769887049,0.828395311357297
CD300E,CMRF35-like molecule 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50724,-2.54290714444062e-05,0.00326135140277858,-0.00641767782089043,0.00636681967800162,0.99377895239913
CD300E,CMRF35-like molecule 2,Working and living environment,X24009.Traffic intensity on the nearest road,52186,-0.114389023665305,0.0583722060069979,-0.228798547439021,2.05001084112449e-05,0.0500489165870339
CD300E,CMRF35-like molecule 2,Working and living environment,X24010.Inverse distance to the nearest road,52186,0.00445987332817157,0.00314114576588169,-0.00169677237295653,0.0106165190292997,0.155672560073295
CD300E,CMRF35-like molecule 2,Working and living environment,X24011.Traffic intensity on the nearest major road,52186,0.00434927373276914,0.00310151429323622,-0.00172969428197386,0.0104282417475121,0.160837233668504
CD300E,CMRF35-like molecule 2,Working and living environment,X24012.Inverse distance to the nearest major road,52186,-0.00366021053061747,0.00316600806151179,-0.00986558633118059,0.00254516526994564,0.24765373997631
CD300E,CMRF35-like molecule 2,Working and living environment,X24013.Total traffic load on major roads,52186,-0.0569983882044477,0.040508926794285,-0.136395884721246,0.022399108312351,0.159423864744775
CD300E,CMRF35-like molecule 2,Working and living environment,X24015.Sum of road length of major roads within 100m,52186,-0.0797050569410877,0.0394103233098174,-0.15694929062833,-0.00246082325384561,0.0431423591799805
CD300E,CMRF35-like molecule 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52186,-0.000165149636037308,0.00357445631784451,-0.00717108401901254,0.00684078474693793,0.963149068756918
CD300E,CMRF35-like molecule 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52186,-0.000258726494345941,0.00356622771429165,-0.00724853281435757,0.00673107982566569,0.942165589337221
CD300E,CMRF35-like molecule 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52186,0.00105698276358854,0.00352619455221484,-0.00585435855875254,0.00796832408592963,0.764369279924902
CD300E,CMRF35-like molecule 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,52132,-0.000971409927606024,0.00351920384513902,-0.0078690494640785,0.00592622960886645,0.782526618367447
CD300E,CMRF35-like molecule 2,Working and living environment,X24020.Average daytime sound level of noise pollution,52186,-0.00488311404802041,0.00316271010516984,-0.0110820258541533,0.00131579775811247,0.122610548450599
CD300E,CMRF35-like molecule 2,Working and living environment,X24021.Average evening sound level of noise pollution,52186,-0.00487645879225582,0.00316315054303129,-0.0110762338565971,0.00132331627208551,0.123173371441883
CD300E,CMRF35-like molecule 2,Working and living environment,X24022.Average night-time sound level of noise pollution,52186,-0.00488901174640111,0.00316274456670129,-0.0110879910971356,0.00130996760433342,0.122163493513023
CD300E,CMRF35-like molecule 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52186,-0.00487170868927554,0.003162815225931,-0.0110708265321003,0.00132740915354922,0.123499126177848
CD300E,CMRF35-like molecule 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52186,-0.00487707773355326,0.00316275662607758,-0.0110760807206653,0.00132192525355879,0.123079133647145
CD300E,CMRF35-like molecule 2,Health and medical history,X2405.Number of children fathered,40165,-0.0990587052136895,0.0445823382528468,-0.186440088189269,-0.0116773222381098,0.0263085532273723
CD300E,CMRF35-like molecule 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49886,0.00109497180017574,0.00364872243166997,-0.0060565241658974,0.00824646776624888,0.764105942795098
CD300E,CMRF35-like molecule 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49886,0.00867944605760858,0.00327757370305651,0.00225540159961783,0.0151034905155993,0.00809994326638801
CD300E,CMRF35-like molecule 2,Working and living environment,"X24502.Water percentage, buffer 1000m",49886,-0.00165427756998332,0.00333056658616767,-0.00818218807887196,0.00487363293890531,0.619409044464936
CD300E,CMRF35-like molecule 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49886,-0.000846848312762937,0.00341890377613402,-0.00754789971398562,0.00585420308845975,0.804372192647759
CD300E,CMRF35-like molecule 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49886,0.00862965491725432,0.0032943768028378,0.00217267638369224,0.0150866334508164,0.00881202870753514
CD300E,CMRF35-like molecule 2,Working and living environment,"X24505.Water percentage, buffer 300m",49886,-0.00279373740733612,0.00335543765104856,-0.0093703952033913,0.00378292038871906,0.405079965106491
CD300E,CMRF35-like molecule 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52326,0.0011440373720761,0.00352257872522891,-0.00576021692937256,0.00804829167352476,0.745356051368482
CD300E,CMRF35-like molecule 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52326,-0.00250486422645823,0.00329486896504473,-0.00896280739794589,0.00395307894502943,0.447123776740784
CD300E,CMRF35-like molecule 2,Working and living environment,X24508.Distance (Euclidean) to coast,52326,0.00482201480004799,0.0031077907192821,-0.00126925500974492,0.0109132846098409,0.120774207529408
CD300E,CMRF35-like molecule 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35558,0.0803478281012113,0.053815281413589,-0.0251301234694231,0.185825779671846,0.135478913927047
CD300E,CMRF35-like molecule 2,Health and medical history,X2704.Years since last cervical smear test,38477,0.0788508802809905,0.0473867991675313,-0.0140272460873708,0.171729006649352,0.0961493591821337
CD300E,CMRF35-like molecule 2,Health and medical history,X2714.Age when periods started (menarche),40943,0.0138131924592394,0.0372149938100541,-0.0591281954084666,0.0867545803269454,0.710515543243841
CD300E,CMRF35-like molecule 2,Health and medical history,X2734.Number of live births,41295,0.0431473528122987,0.0361523708611442,-0.027711294075544,0.114005999700141,0.232702455925072
CD300E,CMRF35-like molecule 2,Health and medical history,X2744.Birth weight of first child,39444,-0.209064870305143,0.0388040916093009,-0.285120889859373,-0.133008850750914,7.29462470638117e-08
CD300E,CMRF35-like molecule 2,Health and medical history,X2754.Age at first live birth,38207,-0.0182850195741173,0.00556331821655888,-0.0291891232785728,-0.00738091586966193,0.00101752449876038
CD300E,CMRF35-like molecule 2,Health and medical history,X2764.Age at last live birth,38177,-0.0117070429271646,0.00511509955862945,-0.0217326380620784,-0.0016814477922509,0.0221185894869761
CD300E,CMRF35-like molecule 2,Health and medical history,X2794.Age started oral contraceptive pill,37119,-0.000460469759313427,0.00787300835496476,-0.0158915661350444,0.0149706266164175,0.953362078404385
CD300E,CMRF35-like molecule 2,Health and medical history,X2804.Age when last used oral contraceptive pill,36332,0.00139224320609244,0.00591386682707201,-0.0101989357749687,0.0129834221871536,0.813889428135306
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2867.Age started smoking in former smokers,36305,-0.0324220443070262,0.00604747281570454,-0.0442750910258071,-0.0205689975882453,8.52438082282533e-08
CD300E,CMRF35-like molecule 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36116,-0.0226737200377482,0.0659129418222098,-0.151863086009279,0.106515645933783,0.730860525365756
CD300E,CMRF35-like molecule 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36112,0.0068458513036059,0.0723243694761882,-0.134909912869723,0.148601615476935,0.924591734928546
CD300E,CMRF35-like molecule 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36129,0.0887021803303793,0.0753276804213353,-0.0589400732954379,0.236344433956197,0.239016101847917
CD300E,CMRF35-like molecule 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36102,0.064043227945373,0.073728783090357,-0.0804651869117267,0.208551642802473,0.385078277372353
CD300E,CMRF35-like molecule 2,Mental health,X28739.Difficulty with standing for long periods,36136,0.375391920723282,0.0566181176086223,0.264420410210382,0.486363431236182,3.60317738633125e-11
CD300E,CMRF35-like molecule 2,Mental health,X28740.Difficulty with taking care of household responsibilities,36158,0.358428181929695,0.0627085134528912,0.235519495562028,0.481336868297362,1.13717100897653e-08
CD300E,CMRF35-like molecule 2,Mental health,X28741.Difficulty learning a new task,36098,0.0634563252978337,0.0715740965211835,-0.0768289038836859,0.203741554479353,0.375334734677153
CD300E,CMRF35-like molecule 2,Mental health,X28742.Difficulty with joining in community activities,35831,0.219042097043084,0.0767480231326887,0.0686159717030141,0.369468222383154,0.0043300555018174
CD300E,CMRF35-like molecule 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36114,0.162443758639325,0.0644278113389003,0.0361652484150803,0.288722268863569,0.0117135089074784
CD300E,CMRF35-like molecule 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36160,0.181916196463279,0.09846002938975,-0.0110654611406311,0.374897854067189,0.0647004906195837
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,35825,0.120884102344148,0.0510981633286039,0.0207317022200839,0.221036502468211,0.0180235030736242
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2897.Age stopped smoking,36307,0.0412047991424536,0.00570496237451834,0.0300230728883977,0.0523865253965096,5.62887373666889e-13
CD300E,CMRF35-like molecule 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35417,0.00410998684760153,0.0123526004998742,-0.0201011101321519,0.028321083827355,0.7393550491208
CD300E,CMRF35-like molecule 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35417,-0.0151575098278628,0.013887970717684,-0.0423779324345234,0.0120629127787979,0.275133510633729
CD300E,CMRF35-like molecule 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35417,0.0699663444891144,0.0451302563934789,-0.0184889580421043,0.158421647020333,0.121115551997427
CD300E,CMRF35-like molecule 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35417,0.0505393209846978,0.0530767472889431,-0.0534911037016306,0.154569745671026,0.341035960418161
CD300E,CMRF35-like molecule 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35417,0.109623599828776,0.0663659970512773,-0.0204537543917273,0.23970095404928,0.0986250258975591
CD300E,CMRF35-like molecule 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35417,-0.0499265831763447,0.0542974927365081,-0.156349668939901,0.0564965025872112,0.357869373411453
CD300E,CMRF35-like molecule 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35417,-0.00272951119517845,0.0224577249413385,-0.0467466520802018,0.0412876296898449,0.903267282786823
CD300E,CMRF35-like molecule 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35417,0.0122562234219869,0.03866273429094,-0.0635227357882555,0.0880351826322292,0.751251554445238
CD300E,CMRF35-like molecule 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35373,0.0425198638547054,0.0771860017781309,-0.108764699630431,0.193804427339842,0.581739065781552
CD300E,CMRF35-like molecule 2,Mental health,X29003.Recent feelings of depression,35363,0.0228749388642251,0.0747915510445385,-0.12371650118307,0.169466378911521,0.759729760962112
CD300E,CMRF35-like molecule 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35374,0.0536227792558726,0.058232865119842,-0.0605136363790178,0.167759194890763,0.357173260691835
CD300E,CMRF35-like molecule 2,Mental health,X29005.Recent feelings of tiredness or low energy,35378,0.179489993029541,0.0576229326232264,0.066549045088017,0.292430940971064,0.00184845869597316
CD300E,CMRF35-like molecule 2,Mental health,X29006.Recent poor appetite or overeating,35389,-0.0115504861961917,0.0894135650809966,-0.186801073754945,0.163700101362562,0.897219045850977
CD300E,CMRF35-like molecule 2,Mental health,X29007.Recent feelings of inadequacy,35353,0.1151185103598,0.0834004229376281,-0.0483463185979507,0.278583339317552,0.167541060554533
CD300E,CMRF35-like molecule 2,Mental health,X29008.Recent trouble concentrating on things,35387,0.00779128342698738,0.0814422960249654,-0.151835616781945,0.16741818363592,0.923788700121921
CD300E,CMRF35-like molecule 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35381,0.0984496366629785,0.13643755092405,-0.168967963148159,0.365867236474116,0.47058439340384
CD300E,CMRF35-like molecule 2,Mental health,X29010.Recent thoughts of suicide or self-harm,35360,0.286579459314547,0.152353148752267,-0.0120327122398961,0.58519163086899,0.060016170999835
CD300E,CMRF35-like molecule 2,Mental health,X29038#0.Substances taken for depression_None of options listed,36401,-0.0380360747872795,0.0268628989707182,-0.0906873567698873,0.0146152071953282,0.15683823100927
CD300E,CMRF35-like molecule 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36401,-0.0584455018519987,0.0693093903202936,-0.194291906879774,0.0774009031757769,0.399113733588699
CD300E,CMRF35-like molecule 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36401,-0.0502778482179347,0.0275657385943554,-0.104306695862871,0.00375099942700197,0.0682047568799938
CD300E,CMRF35-like molecule 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36401,0.180232871719941,0.0842353041981471,0.0151316754915729,0.34533406794831,0.03241769987065
CD300E,CMRF35-like molecule 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36401,-0.110784965748288,0.0699598412450381,-0.247906254588563,0.0263363230919867,0.113339844368558
CD300E,CMRF35-like molecule 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36401,0.00723995144994894,0.0738661790372114,-0.137537759462985,0.152017662362883,0.921923560568531
CD300E,CMRF35-like molecule 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36401,-0.0641811100831423,0.0765773519727101,-0.214272719949654,0.0859104997833696,0.401990373627288
CD300E,CMRF35-like molecule 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36401,0.0295385868241534,0.0756713354391133,-0.118777230636509,0.177854404284815,0.69628654603156
CD300E,CMRF35-like molecule 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36401,-0.0644625686189414,0.0486858892261385,-0.159886911502173,0.03096177426429,0.185528314604604
CD300E,CMRF35-like molecule 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36401,-0.0444830465773379,0.0246447370101569,-0.0927867311172455,0.0038206379625697,0.0711208711344604
CD300E,CMRF35-like molecule 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36401,-0.0384380302202306,0.0436481276491002,-0.123988360412467,0.0471122999720057,0.378545253181008
CD300E,CMRF35-like molecule 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36401,-0.102997803005991,0.0679126285957576,-0.236106555053676,0.0301109490416935,0.129405945211809
CD300E,CMRF35-like molecule 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36401,-0.032413500657499,0.0966765967989188,-0.22189963038338,0.157072629068382,0.737425422024862
CD300E,CMRF35-like molecule 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36401,-0.0927462140314234,0.0647964227267497,-0.219747202575853,0.034254774513006,0.152373935357913
CD300E,CMRF35-like molecule 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36401,-0.0630331723344816,0.0930834013653393,-0.245476639010547,0.119410294341583,0.498320615524894
CD300E,CMRF35-like molecule 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36401,-0.12824689686796,0.0914644071722016,-0.307517134925475,0.0510233411895553,0.160913271979048
CD300E,CMRF35-like molecule 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36401,-0.0316438347413,0.0533874855224205,-0.136283306365244,0.0729956368826441,0.553387096846648
CD300E,CMRF35-like molecule 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36401,-0.0129083322690545,0.0496481435135052,-0.110218693555525,0.0844020290174157,0.794874075578476
CD300E,CMRF35-like molecule 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36401,-0.0489582603476823,0.0706452087389457,-0.187422869476016,0.0895063487806513,0.48832183838166
CD300E,CMRF35-like molecule 2,Mental health,X29058.Recent feelings or nervousness or anxiety,35283,-0.134943941633943,0.0690185098294173,-0.270220220899601,0.000332337631714835,0.0506069583714589
CD300E,CMRF35-like molecule 2,Mental health,X29059.Recent inability to stop or control worrying,35297,-0.00188442661153395,0.0700137611835055,-0.139111398531205,0.135342545308137,0.978528338902704
CD300E,CMRF35-like molecule 2,Mental health,X29060.Recent worrying too much about different things,35293,-0.0841556848094559,0.0652626181953784,-0.212070416472398,0.0437590468534858,0.197275686092127
CD300E,CMRF35-like molecule 2,Mental health,X29061.Recent trouble relaxing,35289,-0.00580300330825479,0.0704764102671453,-0.14393676743186,0.13233076081535,0.934379325971138
CD300E,CMRF35-like molecule 2,Mental health,X29062.Recent restlessness,35306,0.189174859237247,0.102263328843413,-0.0112612652958429,0.389610983770337,0.0643791393819632
CD300E,CMRF35-like molecule 2,Mental health,X29063.Recent easy annoyance or irritability,35277,-0.0256493319122151,0.0722522418818993,-0.167263726000738,0.115965062176307,0.722604120904965
CD300E,CMRF35-like molecule 2,Mental health,X29064.Recent feelings of foreboding,35277,0.0474251965524662,0.0806639828436225,-0.110676209821034,0.205526602925966,0.556597606926616
CD300E,CMRF35-like molecule 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36401,-0.0496156650779948,0.0308189718047753,-0.110020849815354,0.0107895196593648,0.107462050698919
CD300E,CMRF35-like molecule 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36401,-0.103709338432013,0.0550320306873556,-0.211572118579229,0.00415344171520429,0.0595339562488706
CD300E,CMRF35-like molecule 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36401,-0.0442783230837488,0.0672967486914183,-0.176179950518929,0.087623304351431,0.510587195201341
CD300E,CMRF35-like molecule 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36401,0.013599983721883,0.0631185014188159,-0.110112279058996,0.137312246502762,0.829408969844649
CD300E,CMRF35-like molecule 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,36401,-0.0460156836984617,0.0471418721364856,-0.138413753085974,0.0463823856890501,0.329042393630801
CD300E,CMRF35-like molecule 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36401,-0.032956971820574,0.0502439109353219,-0.131435037253805,0.0655210936126569,0.511883914310797
CD300E,CMRF35-like molecule 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36401,-0.0348851834586369,0.0504864947175889,-0.133838713105111,0.0640683461878372,0.489600048726936
CD300E,CMRF35-like molecule 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36401,-0.0813703486588351,0.0507543416446564,-0.180848858282362,0.0181081609646914,0.108930029446014
CD300E,CMRF35-like molecule 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36401,-0.0900380236225683,0.064884665300386,-0.217211967611325,0.0371359203661882,0.165282709633197
CD300E,CMRF35-like molecule 2,Mental health,X29076.Felt loved as a child,35274,-0.0534084942854206,0.0605326697946396,-0.172052527082914,0.065235538512073,0.377644852557299
CD300E,CMRF35-like molecule 2,Mental health,X29077.Physically abused by family as a child,35296,-0.17152435670815,0.0915321932347119,-0.350927455448185,0.00787874203188521,0.0609886999263226
CD300E,CMRF35-like molecule 2,Mental health,X29078.Felt hated by family member as a child,35281,-0.116861644688354,0.0893694215725725,-0.292025710970596,0.0583024215938881,0.191050114107052
CD300E,CMRF35-like molecule 2,Mental health,X29079.Sexually molested as a child,35236,0.0302149478695516,0.112975824607925,-0.191217668361981,0.251647564101084,0.789134813458153
CD300E,CMRF35-like molecule 2,Mental health,X29080.Someone to take to doctor when needed as a child,35254,-0.0556363432177942,0.0824537139988811,-0.217245622655601,0.105972936220013,0.499854973530292
CD300E,CMRF35-like molecule 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35287,0.0637165877737848,0.128990527321173,-0.189104845775714,0.316538021323284,0.621349900790442
CD300E,CMRF35-like molecule 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35241,0.104365420803916,0.0962252657619928,-0.0842361000895896,0.292966941697422,0.278144414894041
CD300E,CMRF35-like molecule 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35293,0.0152196381550207,0.11251460425252,-0.205308986179918,0.23574826248996,0.892404360377368
CD300E,CMRF35-like molecule 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35281,0.232646834458703,0.151022392702733,-0.0633570552386545,0.52865072415606,0.123495610623131
CD300E,CMRF35-like molecule 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35280,0.0793454256406054,0.142636899459592,-0.200222897300195,0.358913748581406,0.578042924954246
CD300E,CMRF35-like molecule 2,Mental health,X29086.Experienced a violent or sexual assault,35295,0.137795275971975,0.135633937624498,-0.12804724177204,0.403637793715991,0.309700592573064
CD300E,CMRF35-like molecule 2,Mental health,X29087.Experienced a life-threatening injury or illness,35288,0.240640877470135,0.0669476393796615,0.109423504285998,0.371858250654271,0.000327629717386839
CD300E,CMRF35-like molecule 2,Mental health,X29088.Experienced a marital separation or divorce,35294,-0.00273680633409202,0.0674482740957246,-0.134935423561712,0.129461810893528,0.967634948318335
CD300E,CMRF35-like molecule 2,Mental health,X29089.Experienced the death of a spouse or partner,35302,0.0408103736480233,0.0723124643843031,-0.100922056545211,0.182542803841257,0.572528834722667
CD300E,CMRF35-like molecule 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35292,0.152313913841778,0.0852119430665267,-0.0147014945686138,0.319329322252171,0.0739109788766685
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29091.Frequency of drinking alcohol,35292,-0.405185804904233,0.0538126972590026,-0.510658691531878,-0.299712918276587,5.83074215536197e-14
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34536,-0.427251257168018,0.0689382813840291,-0.562370288680715,-0.292132225655321,6.1632687985806e-10
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34560,-0.355104552285895,0.0715073282465863,-0.495258915649204,-0.214950188922586,7.04705247555948e-07
CD300E,CMRF35-like molecule 2,Mental health,X29104.Ever used cannabis,35293,-0.0941336330004389,0.100869625589059,-0.291838099154995,0.103570833154118,0.350742936524221
CD300E,CMRF35-like molecule 2,Mental health,X29108.Ever thought that life not worth living,35260,0.0127521776281796,0.0738171567446273,-0.13192944959129,0.157433804847649,0.86285089552942
CD300E,CMRF35-like molecule 2,Mental health,X29109.Ever contemplated self-harm,35284,0.132332254511937,0.109800688017184,-0.0828770940017436,0.347541603025618,0.228171302567563
CD300E,CMRF35-like molecule 2,Mental health,X29111.Ever self-harmed,35292,0.0916823000028765,0.193512666042979,-0.287602525441362,0.470967125447115,0.635674244770537
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35280,-0.170924887564036,0.112941104612902,-0.392289452605324,0.0504396774772515,0.13023042444191
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,37040,-0.109810343697702,0.0726907109075727,-0.252284137076544,0.0326634496811406,0.130917493070466
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,37040,-0.0962471813815417,0.0534024167358702,-0.200915918183847,0.00842155542076385,0.0715365655615308
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,37040,-0.092204654128109,0.0634022536435799,-0.216473071269526,0.0320637630133077,0.145908585526305
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,37040,-0.141344293719554,0.0910843546371484,-0.319869628808365,0.0371810413692565,0.120751490515001
CD300E,CMRF35-like molecule 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35272,-0.152513899414924,0.0630907483244726,-0.27617176613089,-0.0288560326989578,0.0156622125160611
CD300E,CMRF35-like molecule 2,Health and medical history,X29153.Pain or discomfort today,35283,0.224527703351303,0.0569812014153064,0.112844548577302,0.336210858125303,8.22627165876435e-05
CD300E,CMRF35-like molecule 2,Mental health,X29154.Anxiety or depression today,35283,0.0144970625327383,0.0738339445493469,-0.130217468783982,0.159211593849458,0.844345248662106
CD300E,CMRF35-like molecule 2,Mental health,X29166.Frequency of confiding in someone close,35100,-0.00626610655563916,0.0563835190961617,-0.116777803984116,0.104245590872838,0.911514140155872
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35265,0.0237113998235225,0.0119592097258408,0.000271348760874458,0.0471514508861705,0.0474471221600083
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35265,-0.0111414741623744,0.0122409354979412,-0.035133707738339,0.0128507594135903,0.362762884460746
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35265,-0.0214185108801143,0.0153090273269071,-0.0514242044408522,0.00858718268062356,0.161840924926498
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35265,0.00999102728308434,0.0141487358240387,-0.0177404949320315,0.0377225494982002,0.480126462829477
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35265,-0.0477479048906594,0.024357718750646,-0.0954890336419255,-6.77613939326083e-06,0.0500089525323044
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35265,-0.0171933782052175,0.0115561585432605,-0.0398434489500081,0.005456692539573,0.13685271636173
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35263,0.0160189471958691,0.0124421502670907,-0.00836766732762866,0.0404055617193669,0.197978158085098
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35263,-0.0187186729775723,0.0191408501436669,-0.0562347392591594,0.0187973933040149,0.328141171164968
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35263,0.0121206019628065,0.0276894813808143,-0.0421507815435894,0.0663919854692025,0.661595363946003
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35263,0.0155676840270933,0.0221641246557512,-0.0278740002981791,0.0590093683523656,0.482467853634212
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35263,-0.0625512789185105,0.0376376933417499,-0.13632115786834,0.0112186000313192,0.0965780973710873
CD300E,CMRF35-like molecule 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35263,-0.0239149683279134,0.0168854626520234,-0.0570104751258792,0.00918053847005245,0.156737491634723
CD300E,CMRF35-like molecule 2,Mental health,X29171.Frequency of feeling 'in tune' with people,35159,-0.0712682467511827,0.0718736923253686,-0.212140683708905,0.0696041902065397,0.321444503598103
CD300E,CMRF35-like molecule 2,Mental health,X29172.Freuency of feeling that lacks companionship,35244,0.0702552451164922,0.0648467812888609,-0.056844446209675,0.19735493644266,0.278672439925528
CD300E,CMRF35-like molecule 2,Mental health,X29173.Frequency of feeling left out,35201,-0.00548150404710302,0.0693887535498696,-0.141483461004847,0.130520452910641,0.937037633172808
CD300E,CMRF35-like molecule 2,Mental health,X29174.Frequency of feeling isolated from others,35234,-0.00428002501923192,0.0720118710805765,-0.145423292337162,0.136863242298698,0.952607608893317
CD300E,CMRF35-like molecule 2,Mental health,X29175.Tendency to bounce back quickly after hard times,35278,0.0240409459844565,0.0573555183180365,-0.0883758699188951,0.136457761887808,0.675116468360974
CD300E,CMRF35-like molecule 2,Mental health,X29176.Ability to make it through stressful events,35278,0.0285572976644904,0.0547103803065243,-0.0786750477362972,0.135789643065278,0.601708697235927
CD300E,CMRF35-like molecule 2,Mental health,X29177.Quick recovery from stressful events,35278,0.0138679404316304,0.0568395317619433,-0.0975375418217783,0.125273422685039,0.807251386438027
CD300E,CMRF35-like molecule 2,Mental health,X29178.Hard to snap back when something bad happens,35278,0.0199908160953423,0.0549230193657981,-0.087658301861622,0.127639934052307,0.715886475270515
CD300E,CMRF35-like molecule 2,Mental health,X29179.Comes through difficult times with little trouble,35278,0.0270882837871591,0.0562058340732103,-0.0830751509963331,0.137251718570651,0.62986030107632
CD300E,CMRF35-like molecule 2,Mental health,X29180.Tendency to take a long time to get over setbacks,35278,-0.0107850468142191,0.0558200803463005,-0.120192404292968,0.0986223106645299,0.846800271363778
CD300E,CMRF35-like molecule 2,Mental health,X29181.General happiness,35248,0.0356953192628816,0.0580671941799015,-0.0781163813297254,0.149507019855489,0.538759881985323
CD300E,CMRF35-like molecule 2,Mental health,X29182.Belief that own life is meaningful,35156,0.036111659275779,0.0579826717322152,-0.0775343773193627,0.149757695870921,0.533439209039496
CD300E,CMRF35-like molecule 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,35634,-0.0120048062608177,0.0477571671253784,-0.105608853826559,0.0815992413049239,0.801534669130939
CD300E,CMRF35-like molecule 2,Health and medical history,X2946.Father's age,30162,-0.0436076479875503,0.0290300142883592,-0.100506475992734,0.0132911800176337,0.133382619232983
CD300E,CMRF35-like molecule 2,Health and medical history,X2966.Age high blood pressure diagnosed,36859,-0.0340928459570638,0.00639386817518652,-0.0466248275804294,-0.0215608643336982,9.98440225199813e-08
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51722,0.0710318422124417,0.00338372886719535,0.0643997336327388,0.0776639507921446,6.55183413852015e-97
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51723,-0.0123050612844441,0.00359672843109288,-0.0193546490093862,-0.00525547355950206,0.000624603148844406
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30020.Haemoglobin concentration,51723,-0.0568870500265603,0.00384484927448992,-0.0644229546045605,-0.04935114544856,2.66329269796631e-49
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30030.Haematocrit percentage,51723,-0.0411906829616581,0.00375089573653948,-0.0485424386052755,-0.0338389273180407,5.52009107679037e-28
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30040.Mean corpuscular volume,51723,-0.0389307824603334,0.00328749687912267,-0.0453742763434138,-0.0324872885772529,2.94857060008301e-32
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51723,-0.0519108059257166,0.00329166580015652,-0.0583624708940233,-0.0454591409574098,9.8881574125456e-56
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51723,-0.0357531642815941,0.00323117492221775,-0.0420862671291408,-0.0294200614340473,2.19326783290651e-28
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51723,0.067858151938653,0.00331109794959515,0.0613683999574465,0.0743479039198595,1.69410733279524e-92
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30080.Platelet count,51723,0.0130227520607298,0.00327080069353073,0.00661198270140956,0.01943352142005,6.86913019383808e-05
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30090.Platelet crit,51723,0.0287222268292303,0.00332532942882221,0.0222045811487388,0.0352398725097218,6.12585474090412e-18
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51723,0.0212021912615082,0.0031145701497621,0.0150976337679745,0.0273067487550419,1.0186023062223e-11
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30110.Platelet distribution width,51723,0.0112559432453871,0.00323658922097944,0.00491222837226742,0.0175996581185068,0.000506656301504509
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30120.Lymphocyte count,51683,-0.019175493884542,0.00321288551074527,-0.0254727494856027,-0.0128782382834813,2.43316822816481e-09
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30130.Monocyte count,51683,0.124135010334385,0.00318640853419072,0.117889649607372,0.130380371061399,1.66880539388047e-308
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30140.Neutrophill count,51683,0.0687929737833925,0.00335505636309378,0.0622170633117287,0.0753688842550563,1.38620717626505e-92
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30150.Eosinophill count,51683,0.0634864891087182,0.00319893610550948,0.0572165743419196,0.0697564038755168,6.60320123949483e-87
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30160.Basophill count,51683,0.182257002642562,0.0288570569338671,0.125697171052182,0.238816834232941,2.73700101929081e-10
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30170.Nucleated red blood cell count,51683,0.326461999256599,0.133295170990388,0.0652034641154389,0.58772053439776,0.0143263206186513
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30180.Lymphocyte percentage,51684,-0.0749159278265171,0.00316864791964889,-0.0811264777490289,-0.0687053779040053,4.31136163496398e-122
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30190.Monocyte percentage,51684,0.0862802881955311,0.00320028348823626,0.0800077325585881,0.0925528438324742,1.3815671460302e-157
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30200.Neutrophill percentage,51684,0.032321474378246,0.00317691688100077,0.0260947172914845,0.0385482314650075,2.92823724382976e-24
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30210.Eosinophill percentage,51684,0.0396086346312947,0.00319170479200557,0.0333528932389638,0.0458643760236256,3.01392428664806e-35
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30220.Basophill percentage,51684,0.00627137408920558,0.00319450538738033,1.01435299401358e-05,0.012532604648471,0.0496381122496116
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51683,0.325876419509934,0.13335396435584,0.0645026493724868,0.587250189647381,0.0145453415830225
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30240.Reticulocyte percentage,51334,0.0216484059192069,0.00345624394015239,0.0148741677965082,0.0284226440419056,3.83200507171173e-10
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30250.Reticulocyte count,51334,0.018183679160673,0.00351974637846194,0.0112849762588876,0.0250823820624584,2.40984635265005e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30260.Mean reticulocyte volume,51334,0.00954796149294447,0.00323707550013519,0.00320329351267951,0.0158926294732094,0.00318555412573677
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30270.Mean sphered cell volume,51334,-0.0238086263376638,0.00327602663275587,-0.0302296385378653,-0.0173876141374623,3.78260318090583e-13
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30280.Immature reticulocyte fraction,51334,0.0288369268306025,0.00340918395723446,0.0221549262744229,0.035518927386782,2.87131372871806e-17
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51334,0.0297374052732633,0.00352028030703914,0.0228376558714666,0.03663715467506,3.15811082825026e-17
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30300.High light scatter reticulocyte count,51334,0.0272077086502775,0.00356957270697627,0.020211346144604,0.034204071155951,2.59558773710175e-14
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30500.Microalbumin in urine,37208,0.0840029004933142,0.00584541341314096,0.072545890203558,0.0954599107830705,2.95897088864624e-46
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51707,0.0292060450653684,0.00355349098477048,0.0222412027352183,0.0361708873955185,2.16222463500325e-16
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30520.Potassium in urine,51670,-0.0147321310937767,0.00333689832391425,-0.0212724518086486,-0.00819181037890477,1.01519344648152e-05
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30530.Sodium in urine,51650,-0.0303540971907351,0.00350593236347881,-0.0372257246231535,-0.0234824697583166,5.12222196682247e-18
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30600.Albumin,49459,-0.0964841495334729,0.00338937478182437,-0.103127324105849,-0.0898409749610971,8.26835950145471e-175
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30610.Alkaline phosphatase,51294,0.0933978373768763,0.0033503988295352,0.0868310556709873,0.0999646190827653,4.13187563711662e-168
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30620.Alanine aminotransferase,51298,-0.012186741427052,0.00362631445557526,-0.0192943177599795,-0.00507916509412446,0.000778934124858681
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30630.Apolipoprotein A,49319,-0.0835055758321216,0.00373645333052872,-0.0908290243599579,-0.0761821273042853,2.64262951369916e-109
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30640.Apolipoprotein B,51193,-0.0107963191315225,0.00316023112338602,-0.0169903721333591,-0.00460226612968585,0.000635914292776396
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30650.Aspartate aminotransferase,51232,0.0203799676478284,0.00346759619805141,0.0135834790996476,0.0271764561960092,4.23115913064051e-09
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30660.Direct bilirubin,48063,0.00123098061806464,0.00367445932424636,-0.00597095965745822,0.0084329208935875,0.737621266804334
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30670.Urea,51282,0.101434537429882,0.00328354894068782,0.0949987815061341,0.10787029335363,3.5391534637677e-205
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30680.Calcium,49461,-0.0236611808584161,0.00334689371241579,-0.030221092534751,-0.0171012691820811,1.60437327056236e-12
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30690.Cholesterol,51300,-0.03003268090129,0.0031871636491602,-0.036279521653644,-0.023785840148936,4.800513320366e-21
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30700.Creatinine,51291,0.186186664318704,0.00350436117564087,0.179318116414448,0.19305521222296,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30710.C-reactive protein,51236,0.18154772148058,0.0034096827772168,0.174864743237235,0.188230699723925,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30720.Cystatin C,51307,0.3055580066624,0.00305613682896382,0.299567978477631,0.311548034847169,0
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30730.Gamma glutamyltransferase,51294,0.0248244991284024,0.00364522706331434,0.0176798540843063,0.0319691441724985,1.00007179255159e-11
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30740.Glucose,49444,-0.016113004763001,0.00343140176307689,-0.0228385522186317,-0.00938745730737032,2.67371418595018e-06
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),51257,0.0225405881959374,0.0034909294423239,0.0156983664889825,0.0293828099028922,1.09093181491629e-10
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30760.HDL cholesterol,49451,-0.0918112713911085,0.00383254761615414,-0.0993230647187706,-0.0842994780634463,4.41669695170501e-125
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30770.IGF-1,51170,-0.0269884693854766,0.00332702546736884,-0.0335094393015195,-0.0204674994694336,5.24268659120285e-16
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30780.LDL direct,51248,-0.0173829463006488,0.00312908856679633,-0.0235159598915696,-0.011249932709728,2.80374951489512e-08
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30790.Lipoprotein A,46819,0.00857467090132917,0.00355626191613548,0.00160439754570362,0.0155449442569547,0.0159125917336638
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30810.Phosphate,49422,0.0184724057186846,0.00358376484325017,0.0114482266259143,0.0254965848114549,2.56743032693133e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30830.SHBG,49287,0.00746510641908998,0.00415624325383549,-0.000681130358427568,0.0156113431966075,0.0724906506393282
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30840.Total bilirubin,51209,-0.0204301221230839,0.00351145746183498,-0.0273125787482805,-0.0135476654978873,6.03333797055641e-09
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30850.Testosterone,48718,-0.0177721701657254,0.00550679811262862,-0.0285654944664775,-0.00697884586497329,0.00125164106083017
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30860.Total protein,49443,0.0164957136302734,0.00335603426570241,0.00991788646949672,0.0230735407910502,8.9367044861051e-07
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30870.Triglycerides,51285,0.0435189992960761,0.00364073082696728,0.0363831668752202,0.050654831716932,7.87243815362893e-33
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30880.Urate,51267,0.124784747815098,0.00383140864940597,0.117275186862262,0.132294308767933,2.67291925522361e-227
CD300E,CMRF35-like molecule 2,Blood and urine assays,X30890.Vitamin D,50173,-0.0227988170295455,0.00370587359812606,-0.0300623292818725,-0.0155353047772184,7.78595214426457e-10
CD300E,CMRF35-like molecule 2,Physical measures,X3137.Number of measurements made,49837,-0.0144739467493253,0.0346014161793295,-0.082292722460811,0.0533448289621604,0.675728457436955
CD300E,CMRF35-like molecule 2,Physical measures,X3143.Ankle spacing width,42333,0.015399337018404,0.00558621348001625,0.00445035859757216,0.0263483154392359,0.00584741386929269
CD300E,CMRF35-like molecule 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42332,-0.00754796542938994,0.0043443959106122,-0.0160629814141899,0.000967050555409985,0.082339539235403
CD300E,CMRF35-like molecule 2,Physical measures,X3146.Speed of sound through heel,42333,-0.0188630905602177,0.00415868773545639,-0.0270141185217122,-0.0107120625987231,5.78860152213248e-06
CD300E,CMRF35-like molecule 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42333,-0.015431908034129,0.00421166214114998,-0.023686765830783,-0.00717705023747506,0.000249196226764727
CD300E,CMRF35-like molecule 2,Physical measures,X3148.Heel bone mineral density (BMD),42321,-0.015520750656114,0.00421539744823588,-0.0237829296546563,-0.00725857165757168,0.000232413490650913
CD300E,CMRF35-like molecule 2,Health and medical history,X3526.Mother's age at death,48438,-0.0138335489533938,0.00335071375199613,-0.0204009479073062,-0.00726614999948142,3.66615880802328e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X3581.Age at menopause (last menstrual period),38528,-0.0134737860832743,0.00454406802417757,-0.0223801594106623,-0.00456741275588624,0.00303313012202425
CD300E,CMRF35-like molecule 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32834,0.00205658590907482,0.00706978349842794,-0.0118001897478439,0.0159133615659936,0.771145901041822
CD300E,CMRF35-like molecule 2,Physical measures,X4100.Ankle spacing width (left),36797,0.0113750514925982,0.007503747458021,-0.00333229352512291,0.0260823965103194,0.129582144161679
CD300E,CMRF35-like molecule 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36794,-0.0125975949793652,0.00582472153892496,-0.0240140491956581,-0.00118114076307223,0.0305891414234062
CD300E,CMRF35-like molecule 2,Physical measures,X4103.Speed of sound through heel (left),36797,-0.0279458202356858,0.00555779972397292,-0.0388391076946727,-0.0170525327766989,5.06382383118729e-07
CD300E,CMRF35-like molecule 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36797,-0.0231859686321692,0.00563510038542775,-0.0342307653876076,-0.0121411718767308,3.92010381372951e-05
CD300E,CMRF35-like molecule 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),36792,-0.0227790734209239,0.00563699341943267,-0.0338275805230119,-0.0117305663188359,5.37493052801828e-05
CD300E,CMRF35-like molecule 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36797,-0.0231793882697624,0.00563508061847479,-0.034224146281973,-0.0121346302575519,3.93970519630981e-05
CD300E,CMRF35-like molecule 2,Physical measures,X4119.Ankle spacing width (right),36799,0.00667696939486571,0.00739808388920102,-0.00782327502796829,0.0211772138176997,0.366805645434328
CD300E,CMRF35-like molecule 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36798,-0.0175021195252601,0.0058161388699133,-0.0289017517102902,-0.00610248734023006,0.00262766226588167
CD300E,CMRF35-like molecule 2,Physical measures,X4122.Speed of sound through heel (right),36799,-0.0298071184557292,0.00554527123352687,-0.0406758500734419,-0.0189383868380165,7.87539302570222e-08
CD300E,CMRF35-like molecule 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36799,-0.0258736454783374,0.00562324456525893,-0.0368952048262449,-0.0148520861304299,4.26880102812224e-06
CD300E,CMRF35-like molecule 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),36794,-0.0258789084706546,0.00561933752873942,-0.0368928100269839,-0.0148650069143254,4.18510759342158e-06
CD300E,CMRF35-like molecule 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36799,-0.0258696665700251,0.00562323640739197,-0.0368912099285133,-0.0148481232115368,4.28315081474297e-06
CD300E,CMRF35-like molecule 2,Physical measures,X4194.Pulse rate,37145,0.0204172865861506,0.00532715019592063,0.00997607220214617,0.030858500970155,0.000127729515032231
CD300E,CMRF35-like molecule 2,Physical measures,X4195.Pulse wave reflection index,37145,-0.00659005672319326,0.0057702664612289,-0.0178997789872019,0.00471966554081539,0.253458702973958
CD300E,CMRF35-like molecule 2,Physical measures,X4196.Pulse wave peak to peak time,37139,-0.00932013260473984,0.00527015509481611,-0.0196496365905794,0.00100937138109973,0.077020050158847
CD300E,CMRF35-like molecule 2,Physical measures,X4198.Position of the pulse wave peak,37145,0.00391706675716805,0.00563273456985232,-0.0071230929997425,0.0149572265140786,0.486817961253967
CD300E,CMRF35-like molecule 2,Physical measures,X4199.Position of pulse wave notch,37145,0.0142478738293633,0.00539076263681586,0.00368197906120421,0.0248137685975224,0.00823321876816828
CD300E,CMRF35-like molecule 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,37145,0.00885476464639186,0.00554449396619494,-0.00201244352735023,0.019721972820134,0.110297093065632
CD300E,CMRF35-like molecule 2,Physical measures,X4269.Number of triplets attempted (left),36956,-0.025005775965635,0.127006912087918,-0.273939323657955,0.223927771726685,0.843922572586853
CD300E,CMRF35-like molecule 2,Physical measures,X4270.Volume level set by participant (left),36863,0.0126791530838244,0.0440947617036548,-0.0737465798553391,0.0991048860229878,0.773704128463544
CD300E,CMRF35-like molecule 2,Physical measures,X4276.Number of triplets attempted (right),36951,-0.0748219531205007,0.122790363392984,-0.31549106537075,0.165847159129748,0.542312263128174
CD300E,CMRF35-like molecule 2,Physical measures,X4277.Volume level set by participant (right),36855,0.0672307459587112,0.0439844186872977,-0.0189787146683922,0.153440206585815,0.126426574861512
CD300E,CMRF35-like molecule 2,Cognitive function,X4288.Time to answer,37148,0.0059058301970354,0.00632425479730493,-0.00648970920568226,0.0183013695997531,0.350415750689789
CD300E,CMRF35-like molecule 2,Cognitive function,X4290.Duration screen displayed,37148,0.0213851955357515,0.00597004485279499,0.00968390762427335,0.0330864834472297,0.000342901928705768
CD300E,CMRF35-like molecule 2,Physical measures,X46.Hand grip strength (left),52320,-0.0728649495348921,0.00455261958559656,-0.0817880839226614,-0.0639418151471229,2.3952335088493e-57
CD300E,CMRF35-like molecule 2,Physical measures,X47.Hand grip strength (right),52347,-0.06815744315249,0.00453045383352186,-0.0770371326661928,-0.0592777536387871,6.55221918952981e-51
CD300E,CMRF35-like molecule 2,Physical measures,X48.Waist circumference,52411,0.078384145603771,0.00693466408954229,0.0647922039882681,0.0919760872192738,1.51088602127591e-29
CD300E,CMRF35-like molecule 2,Health and medical history,X4803.Tinnitus,37051,0.0445948950108026,0.0490191678874574,-0.0514826740486139,0.140672464070219,0.362985438358218
CD300E,CMRF35-like molecule 2,Working and living environment,X4825.Noisy workplace,37131,0.0713557674557087,0.0555844806412545,-0.0375898146011502,0.180301349512568,0.1992720260079
CD300E,CMRF35-like molecule 2,Working and living environment,X4836.Loud music exposure frequency,37087,-0.072778726516152,0.0943044223187107,-0.257615394260825,0.112057941228521,0.440290089494198
CD300E,CMRF35-like molecule 2,Physical measures,X49.Hip circumference,52406,0.0192672907302151,0.00566514867913746,0.00816359931910568,0.0303709821413245,0.000672477327546654
CD300E,CMRF35-like molecule 2,Physical measures,X50.Standing height,52386,0.0185648632768783,0.00449736922555065,0.00975001959479906,0.0273797069589576,3.67309156008547e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X5057.Number of older siblings,35911,0.0258741022670092,0.0472368024900776,-0.0667100306135429,0.118458235147561,0.583879688886103
CD300E,CMRF35-like molecule 2,Physical measures,X51.Seated height,52292,0.00147967254998901,0.00420078821191069,-0.00675387234535595,0.00971321744533397,0.724663831377507
CD300E,CMRF35-like molecule 2,Eye measures,X5181.Ever had eye surgery,34522,0.229267497089353,0.0954440411631344,0.0421971764096093,0.416337817769096,0.0163346432273086
CD300E,CMRF35-like molecule 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),34507,0.0136646029746403,0.00642247101740711,0.00107655978052234,0.0262526461687582,0.0334141966049057
CD300E,CMRF35-like molecule 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),34507,0.0138038734100604,0.0065971057224158,0.000873546194125394,0.0267342006259953,0.0364488713058412
CD300E,CMRF35-like molecule 2,Eye measures,X5190.Duration at which refractometer first shown (right),34435,0.0114905289376571,0.00676730382874346,-0.00177338656668005,0.0247544444419943,0.0895769693585534
CD300E,CMRF35-like molecule 2,Eye measures,X5193.Duration at which refractometer first shown (left),34434,0.0119065686557354,0.00681911596777644,-0.00145889864110642,0.0252720359525772,0.0808595599690821
CD300E,CMRF35-like molecule 2,Eye measures,"X5199.logMAR, initial (right)",34490,0.0181843988835505,0.0568964430146158,-0.0933326294250964,0.129701427192198,0.749280243009926
CD300E,CMRF35-like molecule 2,Eye measures,X5200.Final number of letters displayed (right),34490,0.180406166995556,0.344746939433849,-0.495297834294788,0.856110168285901,0.600787214208232
CD300E,CMRF35-like molecule 2,Eye measures,"X5201.logMAR, final (right)",34433,0.00313502990126952,0.00712001305765846,-0.0108201956917411,0.0170902554942801,0.659729040035641
CD300E,CMRF35-like molecule 2,Eye measures,X5202.Number of rounds to result (right),34490,-0.0199659956891881,0.051991709243177,-0.121869745805815,0.0819377544274388,0.700977084315235
CD300E,CMRF35-like molecule 2,Eye measures,"X5206.logMAR, initial (left)",34488,0.0487703802565022,0.0571504034288389,-0.063244410464022,0.160785170977026,0.393493345762923
CD300E,CMRF35-like molecule 2,Eye measures,X5207.Final number of letters displayed (left),34488,0.000575784108106927,0.30556813655872,-0.598337763546984,0.599489331763198,0.998496612634448
CD300E,CMRF35-like molecule 2,Eye measures,"X5208.logMAR, final (left)",34426,0.00147373280071213,0.00706631292729118,-0.0123762405367786,0.0153237061382028,0.834801782676732
CD300E,CMRF35-like molecule 2,Eye measures,X5209.Number of rounds to result (left),34486,0.045509333732813,0.0526709557194379,-0.0577257394772854,0.148744406942911,0.38761015281803
CD300E,CMRF35-like molecule 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",34236,-0.0270025173538164,0.00660814724052878,-0.0399544859452529,-0.01405054876238,4.45218109394228e-05
CD300E,CMRF35-like molecule 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",34236,-0.0327365502258107,0.00665881201496859,-0.0457878217751492,-0.0196852786764723,9.10044374623363e-07
CD300E,CMRF35-like molecule 2,Eye measures,X5256.Corneal hysteresis (right),34236,0.00128123506789134,0.00666800029039022,-0.0117880455012735,0.0143505156370562,0.847634937143512
CD300E,CMRF35-like molecule 2,Eye measures,X5257.Corneal resistance factor (right),34236,-0.017423862164075,0.00670934944765162,-0.0305741870814722,-0.00427353724667785,0.00943281285842315
CD300E,CMRF35-like molecule 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",34226,-0.0279893803152296,0.00656803953943078,-0.0408627378125139,-0.0151160228179453,2.06815802279551e-05
CD300E,CMRF35-like molecule 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",34226,-0.0320811840986423,0.00662119919890434,-0.0450587345284948,-0.0191036336687898,1.30267537509458e-06
CD300E,CMRF35-like molecule 2,Eye measures,X5264.Corneal hysteresis (left),34226,0.00267674871931893,0.00674202668970641,-0.0105376235925056,0.0158911210311435,0.69136634717103
CD300E,CMRF35-like molecule 2,Eye measures,X5265.Corneal resistance factor (left),34226,-0.0159139256142863,0.00675196764370009,-0.0291477821959385,-0.00268006903263412,0.0184647434985947
CD300E,CMRF35-like molecule 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34637,-0.392613137519599,0.312427605078431,-1.00497124347332,0.219744968434125,0.208933192245728
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52346,0.065031048426169,0.0169466194102307,0.0318156743821167,0.0982464224702213,0.000124671259387553
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52346,0.0432606462268761,0.0180566875216869,0.00786953868436968,0.0786517537693824,0.0165909375658892
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52346,-0.00657261217705385,0.0481650310801432,-0.100976073094135,0.0878308487400269,0.89145863302953
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52346,-0.0143577576379167,0.00731548215145159,-0.0286961026547618,-1.94126210715621e-05,0.0496983906514116
CD300E,CMRF35-like molecule 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52346,0.000721260349974885,0.00688686813764661,-0.0127770011998125,0.0142195218997622,0.916591119087114
CD300E,CMRF35-like molecule 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38351,-0.0224376891564314,0.0102996293548631,-0.042624962691963,-0.00225041562089979,0.0293946355484856
CD300E,CMRF35-like molecule 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38351,-0.0752564116487771,0.0219851693138579,-0.118347343503939,-0.0321654797936156,0.000621929909026059
CD300E,CMRF35-like molecule 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38351,-0.0246699951490685,0.0271214527611054,-0.0778280425608351,0.028488052262698,0.363051181325841
CD300E,CMRF35-like molecule 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38351,0.0149717870538849,0.0146568245657538,-0.0137555890949925,0.0436991632027623,0.307049739405955
CD300E,CMRF35-like molecule 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52422,0.02034467609795,0.0143695764624664,-0.00781969376848408,0.0485090459643841,0.156842795405755
CD300E,CMRF35-like molecule 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52422,0.02034467609795,0.0143695764624664,-0.00781969376848408,0.0485090459643841,0.156842795405755
CD300E,CMRF35-like molecule 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52422,0.00768758540477508,0.0114689589716468,-0.0147915741796527,0.0301667449892029,0.502676442661457
CD300E,CMRF35-like molecule 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52422,-0.0287259881197006,0.0198756349032467,-0.0676822325300641,0.0102302562906629,0.148390900127761
CD300E,CMRF35-like molecule 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52422,0.0701577196185951,0.0475903315496533,-0.0231193302187252,0.163434769455916,0.140441003135215
CD300E,CMRF35-like molecule 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52422,0.0695341045321279,0.0325291551318559,0.00577696047369028,0.133291248590565,0.0325601735772839
CD300E,CMRF35-like molecule 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52422,-0.0395048877222173,0.0531803832601957,-0.143738438912201,0.0647286634677663,0.457581833964896
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52346,-0.000225916777575862,0.0105746554827075,-0.0209522415236825,0.0205004079685308,0.982955487184745
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52346,0.050854762466494,0.0178093820159604,0.0159483737152115,0.0857611512177764,0.00430067762360122
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52346,0.00264893144781288,0.0105849837471703,-0.0180976366966409,0.0233954995922666,0.802393372605002
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52346,0.0428212741718869,0.0149170825139046,0.0135837924446338,0.0720587558991399,0.00410039027577561
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52346,0.0277574879382614,0.0181910076706768,-0.00789688709626508,0.063411862972788,0.127050767441926
CD300E,CMRF35-like molecule 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52346,0.077573864979902,0.00706030048752721,0.0637356760243487,0.0914120539354554,5.15729906152513e-28
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,38933,0.0805492115523994,0.0174032467681237,0.046438847886877,0.114659575217922,3.7326237318358e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,38933,0.0205085194232945,0.0149270646604225,-0.00874852731113349,0.0497655661577225,0.169499663560616
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,38933,0.11337229222075,0.0214056085535666,0.0714172994557593,0.15532728498574,1.20695839933698e-07
CD300E,CMRF35-like molecule 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,38933,0.0102592069645692,0.0168999679300271,-0.0228647301782839,0.0433831441074222,0.543828684866292
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52339,0.0304414301637213,0.0241827691008238,-0.0169567972738934,0.0778396576013359,0.208112880073012
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52339,0.0478844722426755,0.0374064033712983,-0.0254320783650693,0.12120102285042,0.200517766337674
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52339,0.223043311771408,0.058758229805335,0.107877181352952,0.338209442189865,0.000147454000141787
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52339,0.0400548702701443,0.0611310070616747,-0.0797619035707381,0.159871644111027,0.512326188485121
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52339,0.0274761947106113,0.0200461546503703,-0.0118142684041145,0.0667666578253371,0.17049842518503
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52339,0.029606880609908,0.0278354837045249,-0.0249506674509608,0.0841644286707769,0.287503778854925
CD300E,CMRF35-like molecule 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52339,0.0134622271380013,0.0146535847027541,-0.0152587988793968,0.0421832531553993,0.358262837918905
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",36059,0.140904558178918,0.0201316804000714,0.101446464594778,0.180362651763058,2.81923129174988e-12
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",36059,0.138798495433749,0.0212128531615537,0.0972213032371036,0.180375687630394,6.45827703064024e-11
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",36059,0.122119132313939,0.0295653445088696,0.0641710570765545,0.180067207551323,3.66299497636224e-05
CD300E,CMRF35-like molecule 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",36059,0.00211806279647928,0.0124023876900089,-0.0221906170759381,0.0264267426688967,0.864402864734434
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",40644,0.00323644107743772,0.0098190287949237,-0.0160088553606127,0.0224817375154882,0.741701387872312
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",40644,-0.0537465745720815,0.0115840422116955,-0.0764512973070047,-0.0310418518371584,3.52770866626411e-06
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",40644,0.0218801054862834,0.00960746765093425,0.00304946889045228,0.0407107420821145,0.0227803413310108
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",40644,0.0484275743214135,0.0221339096032363,0.00504511149907043,0.0918100371437566,0.0286944177320672
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",40644,0.0328220572868263,0.0123187977965515,0.00867721360558541,0.0569669009680672,0.00772366124316229
CD300E,CMRF35-like molecule 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",40644,0.0108165687403953,0.0176838296561599,-0.023843737385678,0.0454768748664687,0.540771976157032
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52346,-0.0563889194849895,0.0196993407349002,-0.0949996273253938,-0.0177782116445852,0.00420720136419059
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52346,-0.0190066152955514,0.0149438347068136,-0.0482965313209061,0.0102833007298033,0.203432081990145
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52346,0.0789562566235652,0.0379159913879989,0.00464091350308747,0.153271599744043,0.0373169093935389
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52346,-0.0113131041083178,0.0139269406219853,-0.0386099077274089,0.0159836995107733,0.416617555074598
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52346,-0.0428638570198769,0.0164163193093299,-0.0750398428661636,-0.0106878711735902,0.00903224554532403
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52346,0.116806186856422,0.0197013187295556,0.0781916021464933,0.155420771566351,3.09386637818669e-09
CD300E,CMRF35-like molecule 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52346,0.0252563975157676,0.00661436843520297,0.0122922353827697,0.0382205596487654,0.000134662351336948
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34955,0.0710723863931546,0.0173051495161328,0.0371542933415342,0.104990479444775,4.06367887982543e-05
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34955,0.0861427945962796,0.0212759640432703,0.0444419050714698,0.127843684121089,5.21490293078972e-05
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34955,-0.0753142449719262,0.0148469034321484,-0.104414175698937,-0.0462143142449154,4.04443327187746e-07
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34955,0.0143504922711717,0.0139778137257574,-0.0130460226313129,0.0417470071736563,0.3046226751017
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52446,0.00923960530987689,0.00883449823306619,-0.00807601122693284,0.0265552218466866,0.295638794600001
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52446,0.0299370966852352,0.0245603180597102,-0.0182011267117968,0.0780753200822673,0.222886401306064
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52446,0.0326205407391546,0.00735285264638625,0.0182089495522375,0.0470321319260716,9.18755185293796e-06
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52446,0.01745780105541,0.00707401609696407,0.00359272950536043,0.0313228726054596,0.0135988483993777
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52446,0.0480888965849461,0.012072734650094,0.0244263366707619,0.0717514564991304,6.81819203949321e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52446,0.0333037635235175,0.00905094541543838,0.0155639105092583,0.0510436165377767,0.000234137005583894
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52446,0.0135906596298006,0.00740306277300509,-0.000919343405289336,0.0281006626648906,0.0663976654942488
CD300E,CMRF35-like molecule 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52446,0.190725244753808,0.0226557203015532,0.146320032962764,0.235130456544852,4.0335278748133e-17
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45726,-0.0555966491297895,0.00755414374512437,-0.0704027708702332,-0.0407905273893457,1.92900532944501e-13
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45726,0.0105245787561661,0.00786125309561059,-0.00488347731123069,0.0259326348235628,0.180656970324927
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45726,0.0255614758191972,0.00832654672720519,0.009241444233875,0.0418815074045194,0.00214493933977967
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45726,-0.0422420885877131,0.0113824603946922,-0.0645517109613098,-0.0199324662141163,0.000206991281961059
CD300E,CMRF35-like molecule 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45726,-0.0112126402568765,0.00758944088881978,-0.0260879443989633,0.00366266388521025,0.139587485128775
CD300E,CMRF35-like molecule 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52211,-0.0169764399520274,0.00774033283374803,-0.0321474923061736,-0.0018053875978813,0.0282997584698418
CD300E,CMRF35-like molecule 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52211,-0.0395280695993638,0.0062748099500519,-0.0518266971014656,-0.0272294420972621,3.04041707994145e-10
CD300E,CMRF35-like molecule 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52211,0.000370814899921464,0.00649954703229936,-0.0123682972833853,0.0131099270832282,0.954503931645125
CD300E,CMRF35-like molecule 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52211,-0.0728749748627914,0.0140768044035406,-0.100465511493731,-0.045284438231852,2.27432759546569e-07
CD300E,CMRF35-like molecule 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52230,-0.075779400018561,0.00696522507946453,-0.0894312411743115,-0.0621275588628105,1.68073759070839e-27
CD300E,CMRF35-like molecule 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52230,-0.0588650494128517,0.013814364319604,-0.0859412034792756,-0.0317888953464278,2.04187096220051e-05
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52346,-0.0757106894748741,0.00637297523838857,-0.0882017209421157,-0.0632196580076325,1.86943531517973e-32
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52346,-0.0658054081957006,0.00732041163786078,-0.0801534150059077,-0.0514574013854934,2.67395682275601e-19
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52346,0.0170095750317547,0.0111076316225382,-0.00476138294842015,0.0387805330119295,0.125698726764268
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52346,-0.055528282833591,0.0152745375038551,-0.085466376341147,-0.0255901893260349,0.000278205364935419
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52346,0.066777891952968,0.019360167083849,0.028831964468624,0.104723819437312,0.000563164350100417
CD300E,CMRF35-like molecule 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52346,-0.0482362550860648,0.0183164022449771,-0.0841364034862198,-0.0123361066859098,0.00845658677869501
CD300E,CMRF35-like molecule 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42333,-0.0154295466324171,0.00421164250463793,-0.0236843659415074,-0.00717472732332674,0.000249725388821254
CD300E,CMRF35-like molecule 2,Physical activities,X864.Number of days or week walked 10+ minutes,51852,-0.195105189044456,0.02642990463785,-0.246907802134642,-0.14330257595427,1.61324750228727e-13
CD300E,CMRF35-like molecule 2,Physical activities,X874.Duration of walks,48744,-0.00955065153091425,0.00344085156953094,-0.0162947206071949,-0.0028065824546336,0.00551412809612276
CD300E,CMRF35-like molecule 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50904,-0.21713298156126,0.0257277713811404,-0.267559413468295,-0.166706549654225,3.37995753307285e-17
CD300E,CMRF35-like molecule 2,Physical activities,X894.Duration of moderate activity,46017,-0.0351853654026878,0.0318184236078139,-0.097549475674003,0.0271787448686275,0.268821390991729
CD300E,CMRF35-like molecule 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33497,-0.0268464704962844,0.00786036162996977,-0.0422527792910251,-0.0114401617015437,0.000642720441998956
CD300E,CMRF35-like molecule 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50810,-0.325004249462194,0.0268180081693087,-0.377567545474039,-0.272440953450349,1.07918392322481e-33
CD300E,CMRF35-like molecule 2,Physical activities,X914.Duration of vigorous activity,40456,-0.000943847925303769,0.00408924934984226,-0.0089587766509946,0.00707108080038706,0.817465031124072
